Medications for human use with a single active ingredient starting with the letter D-G

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre D-G

Updated | Mise à jour : 2021-09-02
∙ Product Name | Nom du produit
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercisalisation originale;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN:
Monograph | Monographie
∙ RED-COTE
∙ d&c red no. 28 5 mg;
∙ 1995-12-31;
∙ Dental | Dentaire;
∙ Tablet | Comprimé;
∙ 34:00.00 – DENTAL AGENTS;
∙ Otc | En Vente Libre;
∙ SUNSTAR AMERICAS INC;
∙ DIN: 00690112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18692
∙ PRADAXA
∙ dabigatran etexilate (dabigatran etexilate mesilate) 110 mg;
∙ 2008-07-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02312441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79795
∙ PRADAXA
∙ dabigatran etexilate (dabigatran etexilate mesilate) 150 mg;
∙ 2010-11-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02358808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84384
∙ APO-DABIGATRAN
∙ dabigatran etexilate (dabigatran etexilate mesilate) 150 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95756
∙ PRADAXA
∙ dabigatran etexilate (dabigatran etexilate mesilate) 75 mg;
∙ 2008-07-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02312433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79794
∙ APO-DABIGATRAN
∙ dabigatran etexilate (dabigatran etexilate mesilate) 75 mg;
∙ 2019-08-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468891
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95754
∙ TAFINLAR
∙ dabrafenib (dabrafenib mesylate) 50 mg;
∙ 2013-08-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02409607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89429
∙ TAFINLAR
∙ dabrafenib (dabrafenib mesylate) 75 mg;
∙ 2013-08-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02409615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89430
∙ DACARBAZINE FOR INJECTION BP
∙ dacarbazine 600 mg / vial;
∙ 2000-04-04;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02241445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65081
∙ VIZIMPRO
∙ dacomitinib (dacomitinib monohydrate) 15 mg;
∙ 2019-04-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02486024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97625
∙ VIZIMPRO
∙ dacomitinib (dacomitinib monohydrate) 30 mg;
∙ 2019-04-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02486032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97626
∙ VIZIMPRO
∙ dacomitinib (dacomitinib monohydrate) 45 mg;
∙ 2019-04-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02486040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97627
∙ COSMEGEN
∙ dactinomycin 0.5 mg / vial;
∙ 1963-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ RECORDATI RARE DISEASES CANADA INC;
∙ DIN: 00213071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=250
∙ XYDALBA
∙ dalbavancin (dalbavancin hydrochloride) 500 mg / vial;
∙ 2021-05-28;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.28.16 – GLYCOPEPTIDES;
∙ Prescription | Prescription;
∙ ENDO VENTURES LTD.;
∙ DIN: 02480522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97107
∙ FRAGMIN
∙ dalteparin sodium 10000 unit / ml;
∙ 1995-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02132664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18235
∙ FRAGMIN
∙ dalteparin sodium 10000 unit / 0.4 ml;
∙ 2011-02-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02352656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83791
∙ FRAGMIN
∙ dalteparin sodium 12500 unit / 0.5 ml;
∙ 2011-02-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02352664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83792
∙ FRAGMIN
∙ dalteparin sodium 15000 unit / 0.6 ml;
∙ 2011-02-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02352672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83793
∙ FRAGMIN
∙ dalteparin sodium 16500 unit / 0.66 ml;
∙ 2020-06-08;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02494582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98458
∙ FRAGMIN
∙ dalteparin sodium 18000 unit / 0.72 ml;
∙ 2011-02-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02352680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83794
∙ FRAGMIN
∙ dalteparin sodium 2500 unit / 0.2 ml;
∙ 1995-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02132621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18307
∙ FRAGMIN
∙ dalteparin sodium 25000 unit / ml;
∙ 1997-11-27;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02231171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50478
∙ FRAGMIN
∙ dalteparin sodium 3500 unit / 0.28 ml;
∙ 2015-03-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02430789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91522
∙ FRAGMIN
∙ dalteparin sodium 5000 unit / 0.2 ml;
∙ 1995-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02132648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18306
∙ FRAGMIN
∙ dalteparin sodium 7500 unit / 0.3 ml;
∙ 2011-02-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02352648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83790
∙ ORGARAN
∙ danaparoid sodium 750 unit / 0.6 ml;
∙ 1995-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02129043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18868
∙ CYCLOMEN
∙ danazol 100 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 68:08.00 – ANDROGENS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02018152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15163
∙ CYCLOMEN
∙ danazol 200 mg;
∙ 1972-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 68:08.00 – ANDROGENS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02018160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14747
∙ CYCLOMEN
∙ danazol 50 mg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 68:08.00 – ANDROGENS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02018144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15897
∙ DANTRIUM INTRAVENOUS
∙ dantrolene sodium 20 mg / vial;
∙ 1993-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 12:20.08 – DIRECT-ACTING SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ ENDO PAR INNOVATION COMPANY, LLC;
∙ DIN: 01997572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14017
∙ DANTRIUM CAPSULES
∙ dantrolene sodium 25 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 12:20.08 – DIRECT-ACTING SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ ENDO PAR INNOVATION COMPANY, LLC;
∙ DIN: 01997602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14019
∙ FORXIGA
∙ dapagliflozin (dapagliflozin propanediol monohydrate) 10 mg;
∙ 2015-01-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02435470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91978
∙ FORXIGA
∙ dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg;
∙ 2015-01-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02435462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91977
∙ DAPSONE
∙ dapsone 100 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:16.92 – MISCELLANEOUS ANTIMYCOBACTERIALS;
∙ Prescription | Prescription;
∙ JACOBUS PHARMACEUTICAL COMPANY, INC.;
∙ DIN: 02041510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16584
∙ MAR-DAPSONE
∙ dapsone 100 mg;
∙ 2018-11-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:16.92 – MISCELLANEOUS ANTIMYCOBACTERIALS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02481227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97168
∙ RIVA-DAPSONE
∙ dapsone 100 mg;
∙ 2019-08-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:16.92 – MISCELLANEOUS ANTIMYCOBACTERIALS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02489058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97910
∙ ACZONE
∙ dapsone 5 % / w/w;
∙ 2011-10-21;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02281074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76674
∙ CUBICIN RF
∙ daptomycin 500 mg / vial;
∙ 2018-01-17;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.28.12 – CYCLIC LIPOPEPTIDES;
∙ Prescription | Prescription;
∙ CUBIST PHARMACEUTICALS LLC;
∙ DIN: 02465493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95367
∙ DAPTOMYCIN FOR INJECTION
∙ daptomycin 500 mg / vial;
∙ 2020-11-19;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.28.12 – CYCLIC LIPOPEPTIDES;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02490463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98052
∙ DAPTOMYCIN FOR INJECTION
∙ daptomycin 500 mg / vial;
∙ 2020-10-27;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.28.12 – CYCLIC LIPOPEPTIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02490838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98087
∙ DAPTOMYCIN FOR INJECTION
∙ daptomycin 500 mg / vial;
∙ 2020-10-29;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.28.12 – CYCLIC LIPOPEPTIDES;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02494590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98459
∙ DARZALEX
∙ daratumumab 100 mg / 5 ml;
∙ 2016-07-12;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02455951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94282
∙ DARZALEX SC
∙ daratumumab 1800 mg / 15 ml;
∙ 2020-08-12;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02502712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99226
∙ DARZALEX
∙ daratumumab 400 mg / 20 ml;
∙ 2016-07-12;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02455978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94283
∙ ARANESP
∙ darbepoetin alfa 100 mcg / ml;
∙ 2013-12-11;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87706
∙ ARANESP
∙ darbepoetin alfa 100 mcg / ml;
∙ 2014-05-07;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87707
∙ ARANESP
∙ darbepoetin alfa 100 mcg / ml;
∙ 2014-03-03;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02392348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87762
∙ ARANESP
∙ darbepoetin alfa 200 mcg / ml;
∙ 2014-01-27;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87708
∙ ARANESP
∙ darbepoetin alfa 200 mcg / ml;
∙ 2014-03-26;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87709
∙ ARANESP
∙ darbepoetin alfa 200 mcg / ml;
∙ 2014-02-10;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87710
∙ ARANESP
∙ darbepoetin alfa 200 mcg / ml;
∙ 2014-04-03;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02392356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87763
∙ ARANESP
∙ darbepoetin alfa 25 mcg / ml;
∙ 2013-08-16;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02392313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87760
∙ ARANESP
∙ darbepoetin alfa 40 mcg / ml;
∙ 2014-03-12;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02392321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87761
∙ ARANESP
∙ darbepoetin alfa 500 mcg / ml;
∙ 2014-04-21;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87711
∙ ARANESP
∙ darbepoetin alfa 500 mcg / ml;
∙ 2014-05-05;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87712
∙ ARANESP
∙ darbepoetin alfa 500 mcg / ml;
∙ 2013-11-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02391821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87714
∙ ARANESP
∙ darbepoetin alfa 500 mcg / ml;
∙ 2014-02-24;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02392364
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87764
∙ ENABLEX
∙ darifenacin (darifenacin hydrobromide) 15 mg;
∙ 2006-04-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 86:12.04 – Antimuscarinics;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02273225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75872
∙ APO-DARIFENACIN
∙ darifenacin (darifenacin hydrobromide) 15 mg;
∙ 2021-07-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 86:12.04 – Antimuscarinics;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93889
∙ ENABLEX
∙ darifenacin (darifenacin hydrobromide) 7.5 mg;
∙ 2006-04-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 86:12.04 – Antimuscarinics;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02273217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75871
∙ APO-DARIFENACIN
∙ darifenacin (darifenacin hydrobromide) 7.5 mg;
∙ 2021-07-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 86:12.04 – Antimuscarinics;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93890
∙ NUBEQA
∙ darolutamide 300 mg;
∙ 2020-03-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02496348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98622
∙ PREZISTA
∙ darunavir (darunavir ethanolate) 100 mg / ml;
∙ 2014-08-06;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02416530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90113
∙ PREZISTA
∙ darunavir (darunavir ethanolate) 150 mg;
∙ 2012-04-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02369753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85467
∙ PREZISTA
∙ darunavir (darunavir ethanolate) 600 mg;
∙ 2009-03-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02324024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80950
∙ PREZISTA
∙ darunavir (darunavir ethanolate) 75 mg;
∙ 2009-12-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02338432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82408
∙ PREZISTA
∙ darunavir (darunavir ethanolate) 800 mg;
∙ 2012-11-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02393050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87830
∙ AURO-DARUNAVIR
∙ darunavir (darunavir propylene glycolate) 600 mg;
∙ 2020-03-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02486121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97636
∙ AURO-DARUNAVIR
∙ darunavir (darunavir propylene glycolate) 800 mg;
∙ 2020-03-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02486148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97637
∙ APO-DARUNAVIR
∙ darunavir 600 mg;
∙ 2020-02-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02487241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97741
∙ APO-DARUNAVIR
∙ darunavir 800 mg;
∙ 2020-02-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02487268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97742
∙ SPRYCEL
∙ dasatinib (dasatinib monohydrate) 100 mg;
∙ 2009-05-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02320193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80564
∙ TEVA-DASATINIB
∙ dasatinib (dasatinib monohydrate) 100 mg;
∙ 2021-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02478358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96911
∙ SPRYCEL
∙ dasatinib (dasatinib monohydrate) 140 mg;
∙ 2011-03-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02360829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84582
∙ SPRYCEL
∙ dasatinib (dasatinib monohydrate) 20 mg;
∙ 2007-04-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02293129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77850
∙ TEVA-DASATINIB
∙ dasatinib (dasatinib monohydrate) 20 mg;
∙ 2021-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02478307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96907
∙ SPRYCEL
∙ dasatinib (dasatinib monohydrate) 50 mg;
∙ 2007-04-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02293137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77851
∙ TEVA-DASATINIB
∙ dasatinib (dasatinib monohydrate) 50 mg;
∙ 2021-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02478315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96908
∙ SPRYCEL
∙ dasatinib (dasatinib monohydrate) 70 mg;
∙ 2007-04-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02293145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77852
∙ TEVA-DASATINIB
∙ dasatinib (dasatinib monohydrate) 70 mg;
∙ 2021-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02478323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96909
∙ SPRYCEL
∙ dasatinib (dasatinib monohydrate) 80 mg;
∙ 2011-09-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02360810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84581
∙ TEVA-DASATINIB
∙ dasatinib (dasatinib monohydrate) 80 mg;
∙ 2021-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02478331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96910
∙ APO-DASATINIB
∙ dasatinib 100 mg;
∙ 2020-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02470721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95973
∙ TARO-DASATINIB
∙ dasatinib 100 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98907
∙ TARO-DASATINIB
∙ dasatinib 140 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98908
∙ APO-DASATINIB
∙ dasatinib 20 mg;
∙ 2020-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02470705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95971
∙ TARO-DASATINIB
∙ dasatinib 20 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98902
∙ APO-DASATINIB
∙ dasatinib 50 mg;
∙ 2020-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02470713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95972
∙ TARO-DASATINIB
∙ dasatinib 50 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98904
∙ APO-DASATINIB
∙ dasatinib 70 mg;
∙ 2020-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02481499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97193
∙ TARO-DASATINIB
∙ dasatinib 70 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98905
∙ APO-DASATINIB
∙ dasatinib 80 mg;
∙ 2020-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02481502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97194
∙ TARO-DASATINIB
∙ dasatinib 80 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98906
∙ CERUBIDINE
∙ daunorubicin (daunorubicin hydrochloride) 20 mg / vial;
∙ 1971-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 01926683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13226
∙ DEMYLOCAN
∙ decitabine 50 mg / vial;
∙ 2021-03-24;
∙ Intravenous | Intraveineuse;
∙ Powder | Poudre;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02484811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97510
∙ EXJADE
∙ deferasirox 125 mg;
∙ 2006-11-10;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02287420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77283
∙ APO-DEFERASIROX
∙ deferasirox 125 mg;
∙ 2017-06-26;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02461544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94918
∙ TARO-DEFERASIROX
∙ deferasirox 125 mg;
∙ 2017-06-26;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02463520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95161
∙ SANDOZ DEFERASIROX
∙ deferasirox 125 mg;
∙ 2017-07-04;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02464454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95259
∙ PMS-DEFERASIROX
∙ deferasirox 125 mg;
∙ 2018-04-25;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02474328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96437
∙ JADENU
∙ deferasirox 180 mg;
∙ 2016-03-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02452227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93865
∙ APO-DEFERASIROX (TYPE J)
∙ deferasirox 180 mg;
∙ 2019-05-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02485273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97554
∙ SANDOZ DEFERASIROX (TYPE J)
∙ deferasirox 180 mg;
∙ 2021-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02489902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97997
∙ TARO-DEFERASIROX (TYPE J)
∙ deferasirox 180 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02507323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99673
∙ EXJADE
∙ deferasirox 250 mg;
∙ 2006-11-10;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02287439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77284
∙ APO-DEFERASIROX
∙ deferasirox 250 mg;
∙ 2017-06-29;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02461552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94919
∙ TARO-DEFERASIROX
∙ deferasirox 250 mg;
∙ 2017-06-26;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02463539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95162
∙ SANDOZ DEFERASIROX
∙ deferasirox 250 mg;
∙ 2017-07-04;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02464462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95260
∙ PMS-DEFERASIROX
∙ deferasirox 250 mg;
∙ 2018-04-25;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02474336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96438
∙ JADENU
∙ deferasirox 360 mg;
∙ 2016-03-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02452235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93866
∙ APO-DEFERASIROX (TYPE J)
∙ deferasirox 360 mg;
∙ 2019-05-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02485281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97555
∙ SANDOZ DEFERASIROX (TYPE J)
∙ deferasirox 360 mg;
∙ 2021-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02489910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97998
∙ TARO-DEFERASIROX (TYPE J)
∙ deferasirox 360 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02507331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99674
∙ EXJADE
∙ deferasirox 500 mg;
∙ 2006-11-10;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02287447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77285
∙ APO-DEFERASIROX
∙ deferasirox 500 mg;
∙ 2017-06-26;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02461560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94920
∙ TARO-DEFERASIROX
∙ deferasirox 500 mg;
∙ 2017-06-30;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02463547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95163
∙ SANDOZ DEFERASIROX
∙ deferasirox 500 mg;
∙ 2017-07-04;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02464470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95261
∙ PMS-DEFERASIROX
∙ deferasirox 500 mg;
∙ 2018-04-25;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02474344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96439
∙ JADENU
∙ deferasirox 90 mg;
∙ 2016-03-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02452219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93864
∙ APO-DEFERASIROX (TYPE J)
∙ deferasirox 90 mg;
∙ 2019-05-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02485265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97553
∙ SANDOZ DEFERASIROX (TYPE J)
∙ deferasirox 90 mg;
∙ 2021-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02489899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97996
∙ TARO-DEFERASIROX (TYPE J)
∙ deferasirox 90 mg;
∙ 2021-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02507315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99672
∙ FERRIPROX
∙ deferiprone 100 mg / ml;
∙ 2016-07-28;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ CHIESI CANADA CORP.;
∙ DIN: 02436523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92086
∙ FERRIPROX
∙ deferiprone 1000 mg;
∙ 2015-04-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ CHIESI CANADA CORP.;
∙ DIN: 02436558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92088
∙ FERRIPROX
∙ deferiprone 500 mg;
∙ 2016-03-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ CHIESI CANADA CORP.;
∙ DIN: 02436531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92087
∙ DEFEROXAMINE MESYLATE FOR INJECTION
∙ deferoxamine mesylate 2 g / vial;
∙ 2004-01-12;
∙ Intramuscular , Intraperitoneal , Intravenous , Subcutaneous | Intramusculaire , Intrapéritonéale , Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02247022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71256
∙ DESFERAL 500MG
∙ deferoxamine mesylate 500 mg / vial;
∙ 1992-12-31;
∙ Intramuscular , Intraperitoneal , Intravenous , Subcutaneous | Intramusculaire , Intrapéritonéale , Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 01981242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13546
∙ DEFEROXAMINE MESYLATE FOR INJECTION
∙ deferoxamine mesylate 500 mg / vial;
∙ 2000-04-12;
∙ Intramuscular , Intraperitoneal , Intravenous , Subcutaneous | Intramusculaire , Intrapéritonéale , Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 64:00.00 – HEAVY METAL ANTAGONISTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02241600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65257
∙ DEFITELIO
∙ defibrotide 80 mg / ml;
∙ 2017-09-06;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.20 – THROMBOLYTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JAZZ PHARMACEUTICALS IRELAND LIMITED;
∙ DIN: 02465981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95424
∙ FIRMAGON
∙ degarelix (degarelix acetate) 120 mg / vial;
∙ 2009-11-24;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS , 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02337037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82264
∙ FIRMAGON
∙ degarelix (degarelix acetate) 80 mg / vial;
∙ 2009-11-24;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS , 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02337029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82263
∙ XGEVA
∙ denosumab 120 mg / 1.7 ml;
∙ 2011-06-06;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02368153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85304
∙ PROLIA
∙ denosumab 60 mg / ml;
∙ 2010-08-12;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02343541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82897
∙ BELKYRA
∙ deoxycholic acid 10 mg / ml;
∙ 2016-01-27;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ KYTHERA BIOPHARMACEUTICALS, INC.;
∙ DIN: 02443910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92869
∙ DEQUADIN
∙ dequalinium chloride 0.25 mg;
∙ 1997-04-01;
∙ Oral | Orale;
∙ Lozenge | Pastille;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02100207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28979
∙ DEQUADIN ORAL PAINT
∙ dequalinium chloride 0.5 % / w/v;
∙ 1995-12-31;
∙ Buccal | Buccale;
∙ Solution | Solution;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02091453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19449
∙ ALLERGENIC EXTRACT, STANDARDARDIZED MITE, D. FARINAE
∙ dermatophagoides farinae 10000 unit / ml;
∙ 1997-09-15;
∙ Intradermal , Subcutaneous , Percutaneous | Intradermique , Sous-Cutanée , Percutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALK-ABELLO INC;
∙ DIN: 02217082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43205
∙ ALLERGENIC EXTRACT – STANDARDIZED MITE DERMATOPHAGOIDES FARINAE
∙ dermatophagoides farinae 10000 unit / ml;
∙ 1999-03-15;
∙ Intracutaneous , Subcutaneous | Intracutanée , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ GREER LABORATORIES INC;
∙ DIN: 02231321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50628
∙ ALLERGENIC EXTRACT, STANDARDIZED MITE, D.PTERONYSSINUS
∙ dermatophagoides pteronyssinus 10000 unit / ml;
∙ 1997-09-15;
∙ Intradermal , Subcutaneous , Percutaneous | Intradermique , Sous-Cutanée , Percutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALK-ABELLO INC;
∙ DIN: 02217104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43207
∙ ALLERGENIC EXTRACT – STANDARDIZED MITE DERMATOPHAGOIDES PTERONYSSINUS
∙ dermatophagoides pteronyssinus 10000 unit / ml;
∙ 1999-03-15;
∙ Intracutaneous , Subcutaneous | Intracutanée , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ GREER LABORATORIES INC;
∙ DIN: 02231324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50631
∙ SUPRANE
∙ desflurane 100 % / v/v;
∙ 1996-12-23;
∙ Inhalation | Inhalation;
∙ Liquid | Liquide;
∙ 28:04.16 – INHALATION ANESTHETICS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02227428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43455
∙ DESIPRAMINE
∙ desipramine (desipramine hydrochloride) 10 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02216248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20014
∙ DESIPRAMINE
∙ desipramine (desipramine hydrochloride) 100 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02216280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20021
∙ DESIPRAMINE
∙ desipramine (desipramine hydrochloride) 25 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02216256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20015
∙ DESIPRAMINE
∙ desipramine (desipramine hydrochloride) 50 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02216264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20023
∙ DESIPRAMINE
∙ desipramine (desipramine hydrochloride) 75 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02216272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20022
∙ AERIUS KIDS
∙ desloratadine 0.5 mg / ml;
∙ 2005-03-21;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02247193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71435
∙ AERIUS
∙ desloratadine 5 mg;
∙ 2002-01-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02243919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67861
∙ DESLORATADINE ALLERGY CONTROL
∙ desloratadine 5 mg;
∙ 2009-12-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02298155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78346
∙ DDAVP MELT
∙ desmopressin (desmopressin acetate) 120 mcg;
∙ 2006-11-02;
∙ Sublingual | Sublinguale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02285002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77053
∙ DDAVP MELT
∙ desmopressin (desmopressin acetate) 240 mcg;
∙ 2009-05-05;
∙ Sublingual | Sublinguale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02285010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77054
∙ NOCDURNA
∙ desmopressin (desmopressin acetate) 50 mcg;
∙ 2014-11-17;
∙ Sublingual | Sublinguale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02431076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91551
∙ DDAVP MELT
∙ desmopressin (desmopressin acetate) 60 mcg;
∙ 2006-11-02;
∙ Sublingual | Sublinguale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02284995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77052
∙ PMS-DESMOPRESSIN
∙ desmopressin acetate (desmopressin acetate trihydrate) 0.1 mg;
∙ 2008-01-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02304368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78965
∙ DDAVP TABLETS 0.1MG
∙ desmopressin acetate 0.1 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 00824305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19436
∙ DESMOPRESSIN
∙ desmopressin acetate 0.1 mg;
∙ 2007-01-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02284030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76960
∙ DDAVP TABLETS 0.2MG
∙ desmopressin acetate 0.2 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 00824143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19441
∙ DESMOPRESSIN
∙ desmopressin acetate 0.2 mg;
∙ 2007-01-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02284049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76961
∙ DESMOPRESSIN SPRAY
∙ desmopressin acetate 10 mcg / act;
∙ 2000-08-18;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02242465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66190
∙ OCTOSTIM LIQ INJ. 15MCG/ML
∙ desmopressin acetate 15 mcg / ml;
∙ 1995-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02024179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18289
∙ DDAVP INJ 4MCG/ML
∙ desmopressin acetate 4 mcg / ml;
∙ 1993-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 68:28.00 – PITUITARY;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 00873993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13867
∙ TRIDESILON 0.05% DESONIDE CREAM
∙ desonide .05 %;
∙ 1996-11-11;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02154862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33930
∙ TRIDESILON 0.05% DESONIDE OINTMENT
∙ desonide .05 %;
∙ 1998-01-27;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02154870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33931
∙ PDP-DESONIDE
∙ desonide 0.05 % / w/w;
∙ 1997-01-14;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02229315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43536
∙ PDP-DESONIDE
∙ desonide 0.05 % / w/w;
∙ 1997-01-14;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02229323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43537
∙ TOPICORT
∙ desoximetasone 0.05 %;
∙ 1996-11-07;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02221918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43315
∙ TOPICORT
∙ desoximetasone 0.05 %;
∙ 1996-12-04;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02221926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43316
∙ TOPICORT
∙ desoximetasone 0.25 %;
∙ 1997-03-24;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02221896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43314
∙ TOPICORT
∙ desoximetasone 0.25 %;
∙ 1997-03-24;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02221934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43317
∙ PRISTIQ
∙ desvenlafaxine (desvenlafaxine succinate) 100 mg;
∙ 2009-03-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02321106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80651
∙ PRISTIQ
∙ desvenlafaxine (desvenlafaxine succinate) 50 mg;
∙ 2009-03-05;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02321092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80650
∙ APO-DESVENLAFAXINE
∙ desvenlafaxine 100 mg;
∙ 2017-10-20;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02466996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95540
∙ APO-DESVENLAFAXINE
∙ desvenlafaxine 50 mg;
∙ 2017-10-20;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02466988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95539
∙ DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP
∙ dexamethasone (dexamethasone sodium phosphate) 10 mg / 1 ml;
∙ 1990-12-31;
∙ Intramuscular , Intrasynovial , Intravenous | Intramusculaire , Intrasynoviale , Intraveineuse;
∙ Liquid | Liquide;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00874582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12208
∙ MAXIDEX
∙ dexamethasone 0.1 % / w/v;
∙ 1977-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00042560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2620
∙ MAXIDEX
∙ dexamethasone 0.1 % / w/w;
∙ 1966-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00042579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4591
∙ PMS DEXAMETHASONE TAB 0.5MG USP
∙ dexamethasone 0.5 mg;
∙ 1996-08-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 01964976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23261
∙ APO-DEXAMETHASONE
∙ dexamethasone 0.5 mg;
∙ 2004-11-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02261081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74650
∙ PMS-DEXAMETHASONE ELIXIR
∙ dexamethasone 0.5 mg / 5 ml;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Elixir | Élixir;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 01946897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12967
∙ OZURDEX
∙ dexamethasone 0.7 mg;
∙ 2011-06-02;
∙ Intravitreal | Intravitreuse;
∙ Implant | Implant;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02363445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84844
∙ PMS DEXAMETHASONE TAB 0.75MG USP
∙ dexamethasone 0.75 mg;
∙ 1996-09-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 01964968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23260
∙ PMS-DEXAMETHASONE
∙ dexamethasone 2 mg;
∙ 2006-06-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02279363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76497
∙ PMS DEXAMETHASONE TAB 4MG
∙ dexamethasone 4 mg;
∙ 1996-09-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 01964070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23194
∙ APO-DEXAMETHASONE
∙ dexamethasone 4 mg;
∙ 2004-03-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02250055
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73487
∙ PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML
∙ dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg / ml;
∙ 1990-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 00783900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11011
∙ DEXAMETHASONE-OMEGA
∙ dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg / ml;
∙ 1999-06-30;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02204274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36481
∙ DEXAMETHASONE OMEGA UNIDOSE
∙ dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg / 1 ml;
∙ 2013-05-08;
∙ Intramuscular , Intrasynovial , Intravenous | Intramusculaire , Intrasynoviale , Intraveineuse;
∙ Solution | Solution;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02387743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87333
∙ DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
∙ dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg / ml;
∙ 1986-12-31;
∙ Intramuscular , Intrasynovial , Intravenous | Intramusculaire , Intrasynoviale , Intraveineuse;
∙ Solution | Solution;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00664227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6593
∙ DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
∙ dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg / ml;
∙ 1992-12-31;
∙ Intra-Articular , Intramuscular , Intravenous | Intra-Articulaire , Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 01977547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13255
∙ DEXAMETHASONE-OMEGA
∙ dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg / ml;
∙ 1999-04-01;
∙ Intra-Articular , Intralesional , Intramuscular , Intravenous , Soft Tissue Injection | Intra-Articulaire , Intralésionnelle , Intramusculaire , Intraveineuse , Injection Dans Les Tissus Mous;
∙ Liquid | Liquide;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02204266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36480
∙ DEXAMETHASONE
∙ dexamethasone sodium phosphate 0.1 %;
∙ 1994-12-31;
∙ Ophthalmic , Otic | Ophtalmique , Otique;
∙ Solution | Solution;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ PHARMA STULLN INC.;
∙ DIN: 02023865
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16262
∙ DEXILANT
∙ dexlansoprazole 30 mg;
∙ 2010-08-05;
∙ Nasogastric , Oral | Nasogastrique , Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02354950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84014
∙ DEXILANT
∙ dexlansoprazole 60 mg;
∙ 2010-08-05;
∙ Nasogastric , Oral | Nasogastrique , Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02354969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84015
∙ PRECEDEX
∙ dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
∙ 2010-02-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02339366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82498
∙ DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION
∙ dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
∙ 2019-10-10;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02464381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95254
∙ DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP
∙ dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
∙ 2019-01-15;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02467976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95633
∙ DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION
∙ dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
∙ 2019-03-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02477327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96831
∙ DEXMEDETOMIDINE HYDROCHLORIDE INJECTION
∙ dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg / 50 ml;
∙ 2020-09-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02487365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97754
∙ PRECEDEX
∙ dexmedetomidine (dexmedetomidine hydrochloride) 4 mcg / ml;
∙ 2016-05-09;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02437147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92145
∙ DEXMEDETOMIDINE HYDROCHLORIDE INJECTION
∙ dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg / 100 ml;
∙ 2020-09-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02487373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97755
∙ ZINECARD
∙ dexrazoxane 250 mg / vial;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02153432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18480
∙ DEXEDRINE SPANSULE SRC 10MG
∙ dextroamphetamine sulfate 10 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Capsule (Sustained-Release) | Capsule (À Action Soutenue);
∙ 28:20.04 – AMPHETAMINES;
∙ Schedule G (Cdsa I) | Annexe G (Lrcdas I);
∙ PALADIN LABS INC.;
∙ DIN: 01924559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15211
∙ ACT DEXTROAMPHETAMINE SR
∙ dextroamphetamine sulfate 10 mg;
∙ 2017-10-06;
∙ Oral | Orale;
∙ Capsule (Sustained-Release) | Capsule (À Action Soutenue);
∙ 28:20.04 – AMPHETAMINES;
∙ Schedule G (Cdsa I) | Annexe G (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02448319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93401
∙ DEXEDRINE SPANSULE SRC 15MG
∙ dextroamphetamine sulfate 15 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Capsule (Sustained-Release) | Capsule (À Action Soutenue);
∙ 28:20.04 – AMPHETAMINES;
∙ Schedule G (Cdsa I) | Annexe G (Lrcdas I);
∙ PALADIN LABS INC.;
∙ DIN: 01924567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15210
∙ ACT DEXTROAMPHETAMINE SR
∙ dextroamphetamine sulfate 15 mg;
∙ 2017-10-06;
∙ Oral | Orale;
∙ Capsule (Sustained-Release) | Capsule (À Action Soutenue);
∙ 28:20.04 – AMPHETAMINES;
∙ Schedule G (Cdsa I) | Annexe G (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02448327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93402
∙ DEXEDRINE TABLETS (5MG)
∙ dextroamphetamine sulfate 5 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:20.04 – AMPHETAMINES;
∙ Schedule G (Cdsa I) | Annexe G (Lrcdas I);
∙ PALADIN LABS INC.;
∙ DIN: 01924516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15225
∙ DEXTROAMPHETAMINE
∙ dextroamphetamine sulfate 5 mg;
∙ 2015-08-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:20.04 – AMPHETAMINES;
∙ Schedule G (Cdsa I) | Annexe G (Lrcdas I);
∙ AA PHARMA INC;
∙ DIN: 02443236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92781
∙ ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX
∙ dextromethorphan hydrobromide 15 mg;
∙ 2005-08-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02252554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73742
∙ BRONCHOPHAN FORTE DM SYR
∙ dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00522791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4590
∙ KOFFEX DM (SUCROSE FREE)
∙ dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 01928791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11847
∙ KOFFEX DM
∙ dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 01928783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11848
∙ BALMINIL DM (3MG/ML SUCROSE FREE)
∙ dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 01928775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12788
∙ BUCKLEY’S DRY COUGH EXTRA STRENGTH
∙ dextromethorphan hydrobromide 15 mg / 5 ml;
∙ 2021-08-03;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ THE BUCKLEY’S COMPANY;
∙ DIN: 02511320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100054
∙ BENYLIN EXTRA STRENGTH DRY COUGH
∙ dextromethorphan hydrobromide 30 mg / 10 ml;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 01944738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12411
∙ DRY COUGH RELIEF EXTRA STRENGTH
∙ dextromethorphan hydrobromide 30 mg / 10 ml;
∙ 2013-07-19;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89069
∙ VICKS DAYQUIL COUGH
∙ dextromethorphan hydrobromide 5 mg / 5 ml;
∙ 2010-08-19;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02283913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76949
∙ ADULT HONEY WORKS
∙ dextromethorphan hydrobromide 5 mg / 5 ml;
∙ 2018-10-09;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ LIFELAB HEALTH LLC;
∙ DIN: 02464896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95309
∙ KIDS HONEY WORKS
∙ dextromethorphan hydrobromide 5 mg / 5 ml;
∙ 2018-10-09;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ LIFELAB HEALTH LLC;
∙ DIN: 02464918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95310
∙ BENYLIN FOR CHILDREN DRY COUGH
∙ dextromethorphan hydrobromide 7.5 mg / 5 ml;
∙ 1996-09-18;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02215268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37038
∙ DEXTROSE 5% INJECTION
∙ dextrose (dextrose monohydrate) 50 mg / ml;
∙ 2014-01-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02403536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88832
∙ 10% DEXTROSE INJECTION, USP
∙ dextrose 10 g / 100 ml;
∙ 1997-08-13;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060364
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59976
∙ DEXTROSE INJECTION USP
∙ dextrose 100 mg / ml;
∙ 1951-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00037958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1748
∙ 10% DEXTROSE INJECTION USP
∙ dextrose 100 mg / ml;
∙ 1993-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01924427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14251
∙ DEXTROSE INJECTION USP
∙ dextrose 200 mg / ml;
∙ 1980-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00037966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3747
∙ DEXTROSE-45 5.55-4.5
∙ dextrose 222.7 g / bottle;
∙ 1995-12-31;
∙ Dialysis | Dialyse;
∙ Powder | Poudre;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02160978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18319
∙ 5% DEXTROSE INJECTION, USP
∙ dextrose 5 g / 100 ml;
∙ 1990-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00060348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10511
∙ DEXTROSE INJECTION USP
∙ dextrose 50 mg / ml;
∙ 1978-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00037915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2902
∙ 5% DEXTROSE INJECTION USP
∙ dextrose 50 mg / ml;
∙ 1993-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01924281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13714
∙ DEXTROSE INJECTION USP
∙ dextrose 500 mg / ml;
∙ 1951-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00037974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1746
∙ DEXTROSE INJECTION USP
∙ dextrose 500 mg / ml;
∙ 2020-08-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 02468514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95694
∙ 70% DEXTROSE INJECTION USP
∙ dextrose 70 g / 100 ml;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02014874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18686
∙ DEXTROSE INJECTION USP
∙ dextrose 700 mg / ml;
∙ 1979-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00244988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3585
∙ DIAZEPAM
∙ diazepam 10 mg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00405337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3291
∙ DIAZEPAM
∙ diazepam 2 mg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00405329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3290
∙ DIAZEPAM
∙ diazepam 5 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00362158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2657
∙ VALIUM 5 TAB
∙ diazepam 5 mg;
∙ 1978-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 00013285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3178
∙ DIAZEPAM INJECTION USP
∙ diazepam 5 mg / ml;
∙ 1980-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00399728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3721
∙ DIAZEPAM INJECTION USP
∙ diazepam 5 mg / ml;
∙ 2017-03-16;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02385392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87102
∙ DIASTAT
∙ diazepam 5 mg / 1 ml;
∙ 2000-01-28;
∙ Rectal | Rectale;
∙ Gel | Gel;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02238162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61553
∙ PROGLYCEM
∙ diazoxide 100 mg;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:08.20 – DIRECT VASODILATORS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 00503347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6269
∙ VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH
∙ diclofenac diethylamine 1.16 % / w/w;
∙ 2010-06-21;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02338580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82423
∙ VOLTAREN EMULGEL BACK & MUSCLE PAIN
∙ diclofenac diethylamine 1.16 % / w/w;
∙ 2018-03-15;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02465035
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95324
∙ VOLTAREN EMULGEL EXTRA STRENGTH
∙ diclofenac diethylamine 2.32 %;
∙ 2014-10-06;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02393190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87843
∙ VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH
∙ diclofenac diethylamine 2.32 % / w/w;
∙ 2018-06-27;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02465043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95325
∙ VOLTAREN RAPIDE
∙ diclofenac potassium 50 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00881635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13805
∙ TEVA-DICLOFENAC-K
∙ diclofenac potassium 50 mg;
∙ 1999-01-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02239355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62824
∙ PMS-DICLOFENAC K
∙ diclofenac potassium 50 mg;
∙ 1999-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02239753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63235
∙ SANDOZ DICLOFENAC RAPIDE
∙ diclofenac potassium 50 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02261774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74714
∙ CAMBIA
∙ diclofenac potassium 50 mg / sachet;
∙ 2012-06-02;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 28:32.92 – ANTIMIGRAINE AGENTS, MISCELLANEOUS;
∙ Prescription | Prescription;
∙ ARALEZ PHARMACEUTICALS CANADA INC;
∙ DIN: 02381680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86754
∙ VOLTAREN OPHTHA
∙ diclofenac sodium 0.1 % / w/v;
∙ 1991-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 01940414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11969
∙ SANDOZ DICLOFENAC OPHTHA
∙ diclofenac sodium 0.1 % / w/v;
∙ 2016-09-29;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02454807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94156
∙ DICLOFENAC
∙ diclofenac sodium 0.1 % / w/v;
∙ 2019-03-29;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:02.00 – ANTIALLERGIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMA STULLN INC.;
∙ DIN: 02475065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96535
∙ MINT-DICLOFENAC
∙ diclofenac sodium 0.1 % / w/v;
∙ 2020-09-09;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02475197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96551
∙ PENNSAID
∙ diclofenac sodium 1.5 % / w/w;
∙ 2003-04-01;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02247265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71508
∙ PMS-DICLOFENAC
∙ diclofenac sodium 1.5 % / w/w;
∙ 2014-12-02;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02356783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84191
∙ TARO-DICLOFENAC
∙ diclofenac sodium 1.5 % / w/w;
∙ 2014-03-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02420988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90557
∙ DICLOFENAC TOPICAL SOLUTION
∙ diclofenac sodium 1.5 % / w/w;
∙ 2015-11-23;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02434571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91890
∙ JAMP DICLOFENAC TOPICAL SOLUTION
∙ diclofenac sodium 1.5 % / w/w;
∙ 2018-07-13;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02472309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96140
∙ DICLOFENAC SODIUM SOLUTION
∙ diclofenac sodium 1.5 % / w/w;
∙ 2018-08-22;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02476134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96706
∙ VOLTAREN SR
∙ diclofenac sodium 100 mg;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00590827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6379
∙ VOLTAREN
∙ diclofenac sodium 100 mg;
∙ 1985-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00632732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6462
∙ PMS-DICLOFENAC-SR
∙ diclofenac sodium 100 mg;
∙ 1997-11-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02231505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50845
∙ PMS-DICLOFENAC
∙ diclofenac sodium 100 mg;
∙ 1998-08-07;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02231508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50848
∙ SANDOZ-DICLOFENAC SR
∙ diclofenac sodium 100 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02261944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74729
∙ APO-DICLO SR
∙ diclofenac sodium 100 mg / srt;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02091194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16471
∙ TEVA-DICLOFENAC EC
∙ diclofenac sodium 25 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00808539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9888
∙ APO-DICLO
∙ diclofenac sodium 25 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00839175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10036
∙ PMS-DICLOFENAC
∙ diclofenac sodium 25 mg;
∙ 2008-05-12;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02302616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78791
∙ VOLTAREN
∙ diclofenac sodium 50 mg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00514012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4043
∙ VOLTAREN
∙ diclofenac sodium 50 mg;
∙ 1985-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00632724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6461
∙ TEVA-DICLOFENAC EC
∙ diclofenac sodium 50 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00808547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9889
∙ APO-DICLO
∙ diclofenac sodium 50 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00839183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10037
∙ DICLOFENAC-50
∙ diclofenac sodium 50 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00870978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10772
∙ PMS-DICLOFENAC
∙ diclofenac sodium 50 mg;
∙ 1998-08-07;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02231506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50847
∙ SANDOZ-DICLOFENAC
∙ diclofenac sodium 50 mg;
∙ 2008-10-01;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02261928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74727
∙ PMS-DICLOFENAC
∙ diclofenac sodium 50 mg;
∙ 2008-05-12;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02302624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78792
∙ VOLTAREN SR
∙ diclofenac sodium 75 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00782459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9943
∙ TEVA-DICLOFENAC SR
∙ diclofenac sodium 75 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02158582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18239
∙ APO-DICLO SR
∙ diclofenac sodium 75 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02162814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19125
∙ PMS-DICLOFENAC-SR
∙ diclofenac sodium 75 mg;
∙ 1997-11-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02231504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50844
∙ SANDOZ-DICLOFENAC SR
∙ diclofenac sodium 75 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02261901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74726
∙ JAMP-DICYCLOMINE HCL
∙ dicyclomine hydrochloride 10 mg;
∙ 2012-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02391619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87694
∙ JAMP-DICYCLOMINE HCL
∙ dicyclomine hydrochloride 20 mg;
∙ 2011-08-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02366088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85095
∙ VISANNE
∙ dienogest 2 mg;
∙ 2011-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:32.00 – PROGESTINS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02374900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86025
∙ ASPEN-DIENOGEST
∙ dienogest 2 mg;
∙ 2020-04-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:32.00 – PROGESTINS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02493055
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98304
∙ JAMP DIENOGEST
∙ dienogest 2 mg;
∙ 2020-12-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:32.00 – PROGESTINS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02498189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98796
∙ DUREZOL
∙ difluprednate 0.05 % / w/v;
∙ 2014-02-19;
∙ Ophthalmic | Ophtalmique;
∙ Emulsion | Émulsion;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02415534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90012
∙ TOLOXIN
∙ digoxin 0.05 mg / ml;
∙ 2001-06-01;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 24:04.08 – CARDIOTONIC AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02242320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66031
∙ TOLOXIN
∙ digoxin 0.0625 mg;
∙ 2009-12-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.08 – CARDIOTONIC AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02335700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82129
∙ TOLOXIN
∙ digoxin 0.125 mg;
∙ 2009-12-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.08 – CARDIOTONIC AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02335719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82130
∙ DIGOXIN INJECTION C.S.D.
∙ digoxin 0.5 mg / 2 ml;
∙ 1994-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 24:04.08 – CARDIOTONIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02048264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15757
∙ DIGIFAB
∙ digoxin immune fab (ovine) 40 mg / vial;
∙ 2011-11-04;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:12.00 – ANTIDOTES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BTG INTERNATIONAL INC;
∙ DIN: 02361043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84609
∙ MIGRANAL NASAL SPRAY 4MG/ML
∙ dihydroergotamine mesylate 0.5 mg / act;
∙ 1996-11-05;
∙ Nasal | Nasale;
∙ Liquid | Liquide;
∙ 12:16.00 – SYMPATHOLYTIC (ADRENERGIC BLOCKING) AGENTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02228947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43498
∙ DIHYDROERGOTAMINE (DHE), 1MG/ML
∙ dihydroergotamine mesylate 1 mg / ml;
∙ 1946-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 12:16.00 – SYMPATHOLYTIC (ADRENERGIC BLOCKING) AGENTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 00027243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=415
∙ APO-DILTIAZ CD
∙ diltiazem hydrochloride 120 mg;
∙ 1997-03-27;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02230997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50278
∙ TIAZAC
∙ diltiazem hydrochloride 120 mg;
∙ 1997-06-09;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02231150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50458
∙ TEVA-DILTIAZEM CD
∙ diltiazem hydrochloride 120 mg;
∙ 2000-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66289
∙ SANDOZ DILTIAZEM CD
∙ diltiazem hydrochloride 120 mg;
∙ 2001-02-20;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67243
∙ SANDOZ DILTIAZEM T
∙ diltiazem hydrochloride 120 mg;
∙ 2006-01-26;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02245918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70038
∙ TIAZAC XC
∙ diltiazem hydrochloride 120 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02256738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74195
∙ TEVA-DILTIAZEM HCL ER CAPSULES
∙ diltiazem hydrochloride 120 mg;
∙ 2006-01-30;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ VALEANT CANADA LP / VALEANT CANADA S.E.C.;
∙ DIN: 02271605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75715
∙ ACT DILTIAZEM T
∙ diltiazem hydrochloride 120 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85560
∙ ACT DILTIAZEM CD
∙ diltiazem hydrochloride 120 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85575
∙ DILTIAZEM CD
∙ diltiazem hydrochloride 120 mg;
∙ 2015-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02445999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93126
∙ MAR-DILTIAZEM T
∙ diltiazem hydrochloride 120 mg;
∙ 2018-05-28;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02465353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95355
∙ MAR-DILTIAZEM CD
∙ diltiazem hydrochloride 120 mg;
∙ 2020-03-30;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02484064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97439
∙ JAMP DILTIAZEM T
∙ diltiazem hydrochloride 120 mg;
∙ 2021-07-03;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02495376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98529
∙ APO-DILTIAZ CD
∙ diltiazem hydrochloride 180 mg;
∙ 1997-03-27;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02230998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50279
∙ TIAZAC
∙ diltiazem hydrochloride 180 mg;
∙ 1997-06-09;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02231151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50459
∙ TEVA-DILTIAZEM CD
∙ diltiazem hydrochloride 180 mg;
∙ 2000-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66290
∙ SANDOZ DILTIAZEM CD
∙ diltiazem hydrochloride 180 mg;
∙ 2001-02-20;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67244
∙ SANDOZ DILTIAZEM T
∙ diltiazem hydrochloride 180 mg;
∙ 2006-01-26;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02245919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70039
∙ TIAZAC XC
∙ diltiazem hydrochloride 180 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02256746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74196
∙ TEVA-DILTIAZEM HCL ER CAPSULES
∙ diltiazem hydrochloride 180 mg;
∙ 2006-01-30;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ VALEANT CANADA LP / VALEANT CANADA S.E.C.;
∙ DIN: 02271613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75716
∙ ACT DILTIAZEM T
∙ diltiazem hydrochloride 180 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85564
∙ ACT DILTIAZEM CD
∙ diltiazem hydrochloride 180 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85576
∙ DILTIAZEM CD
∙ diltiazem hydrochloride 180 mg;
∙ 2015-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02446006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93127
∙ MAR-DILTIAZEM T
∙ diltiazem hydrochloride 180 mg;
∙ 2018-05-28;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02465361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95356
∙ MAR-DILTIAZEM CD
∙ diltiazem hydrochloride 180 mg;
∙ 2020-03-30;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02484072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97440
∙ JAMP DILTIAZEM T
∙ diltiazem hydrochloride 180 mg;
∙ 2021-07-03;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02495384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98530
∙ APO-DILTIAZ CD
∙ diltiazem hydrochloride 240 mg;
∙ 1997-03-27;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02230999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50280
∙ TIAZAC
∙ diltiazem hydrochloride 240 mg;
∙ 1997-06-09;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02231152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50460
∙ TEVA-DILTIAZEM CD
∙ diltiazem hydrochloride 240 mg;
∙ 2000-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66291
∙ SANDOZ DILTIAZEM CD
∙ diltiazem hydrochloride 240 mg;
∙ 2001-02-20;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67245
∙ TIAZAC XC
∙ diltiazem hydrochloride 240 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02256754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74197
∙ TEVA-DILTIAZEM HCL ER CAPSULES
∙ diltiazem hydrochloride 240 mg;
∙ 2006-01-30;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ VALEANT CANADA LP / VALEANT CANADA S.E.C.;
∙ DIN: 02271621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75717
∙ ACT DILTIAZEM T
∙ diltiazem hydrochloride 240 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85565
∙ DILTIAZEM CD
∙ diltiazem hydrochloride 240 mg;
∙ 2015-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02446014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93128
∙ MAR-DILTIAZEM T
∙ diltiazem hydrochloride 240 mg;
∙ 2018-05-28;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02465388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95357
∙ MAR-DILTIAZEM CD
∙ diltiazem hydrochloride 240 mg;
∙ 2020-03-30;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02484080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97441
∙ JAMP DILTIAZEM T
∙ diltiazem hydrochloride 240 mg;
∙ 2021-07-03;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02495392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98531
∙ AA-DILTIAZ
∙ diltiazem hydrochloride 30 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00771376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9172
∙ APO-DILTIAZ CD
∙ diltiazem hydrochloride 300 mg;
∙ 1996-09-12;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02229526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47431
∙ TIAZAC
∙ diltiazem hydrochloride 300 mg;
∙ 1997-06-09;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02231154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50461
∙ TEVA-DILTIAZEM CD
∙ diltiazem hydrochloride 300 mg;
∙ 2000-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66292
∙ SANDOZ DILTIAZEM CD
∙ diltiazem hydrochloride 300 mg;
∙ 2001-02-20;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67246
∙ TIAZAC XC
∙ diltiazem hydrochloride 300 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02256762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74198
∙ TEVA-DILTIAZEM HCL ER CAPSULES
∙ diltiazem hydrochloride 300 mg;
∙ 2006-01-30;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ VALEANT CANADA LP / VALEANT CANADA S.E.C.;
∙ DIN: 02271648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75718
∙ ACT DILTIAZEM T
∙ diltiazem hydrochloride 300 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85566
∙ ACT DILTIAZEM CD
∙ diltiazem hydrochloride 300 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370654
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85578
∙ DILTIAZEM CD
∙ diltiazem hydrochloride 300 mg;
∙ 2015-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02446022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93129
∙ MAR-DILTIAZEM T
∙ diltiazem hydrochloride 300 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02465396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95358
∙ MAR-DILTIAZEM CD
∙ diltiazem hydrochloride 300 mg;
∙ 2020-03-30;
∙ Oral | Orale;
∙ Capsule (Controlled-Delivery) | Capsule (À Libération Contrôlée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02484099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97442
∙ JAMP DILTIAZEM T
∙ diltiazem hydrochloride 300 mg;
∙ 2021-07-03;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02495406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98532
∙ TIAZAC
∙ diltiazem hydrochloride 360 mg;
∙ 1997-06-09;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02231155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50462
∙ TIAZAC XC
∙ diltiazem hydrochloride 360 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02256770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74199
∙ TEVA-DILTIAZEM HCL ER CAPSULES
∙ diltiazem hydrochloride 360 mg;
∙ 2006-01-30;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ VALEANT CANADA LP / VALEANT CANADA S.E.C.;
∙ DIN: 02271656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75719
∙ ACT DILTIAZEM T
∙ diltiazem hydrochloride 360 mg;
∙ 2011-10-06;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02370522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85567
∙ MAR-DILTIAZEM T
∙ diltiazem hydrochloride 360 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02465418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95359
∙ JAMP DILTIAZEM T
∙ diltiazem hydrochloride 360 mg;
∙ 2021-07-03;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02495414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98533
∙ DILTIAZEM HYDROCHLORIDE INJECTION
∙ diltiazem hydrochloride 5 mg / ml;
∙ 2002-01-09;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02244728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68717
∙ AA-DILTIAZ
∙ diltiazem hydrochloride 60 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00771384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9173
∙ DIMENHYDRINATE INJ 10MG
∙ dimenhydrinate 10 mg / ml;
∙ 1973-12-31;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00392731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3595
∙ GRAVOL SUPPOSITORIES
∙ dimenhydrinate 100 mg;
∙ 1951-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00013609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=193
∙ CONFAB DIMENHYDRINATE 100 MG
∙ dimenhydrinate 100 mg;
∙ 1974-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ LABORATOIRES CONFAB INC;
∙ DIN: 00392545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2890
∙ GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS
∙ dimenhydrinate 100 mg;
∙ 2005-02-10;
∙ Oral | Orale;
∙ Tablet (Combined Release) | Comprimé (À Action Combinée);
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02254409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73930
∙ KIDS GRAVOL CHEWABLES
∙ dimenhydrinate 15 mg;
∙ 2012-11-14;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02384116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86986
∙ KIDS GRAVOL LIQUID
∙ dimenhydrinate 15 mg / 5 ml;
∙ 1951-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00230197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1256
∙ KIDS GRAVOL SUPPOSITORIES
∙ dimenhydrinate 25 mg;
∙ 1989-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00783595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9585
∙ CONFAB DIMENHYDRINATE 50 MG
∙ dimenhydrinate 50 mg;
∙ 1974-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ LABORATOIRES CONFAB INC;
∙ DIN: 00392553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2891
∙ GRAVOL TABLETS
∙ dimenhydrinate 50 mg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00013803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3944
∙ TRAVEL TABS 50 MG
∙ dimenhydrinate 50 mg;
∙ 1984-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 00605786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5572
∙ DIMENHYDRINATE TABLETS
∙ dimenhydrinate 50 mg;
∙ 2001-11-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02006669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=25821
∙ ANTI-NAUSEANT
∙ dimenhydrinate 50 mg;
∙ 2000-05-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02241532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65184
∙ JAMP-DIMENHYDRINATE
∙ dimenhydrinate 50 mg;
∙ 2003-07-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02245416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69468
∙ GRAVOL LIQUID GELS
∙ dimenhydrinate 50 mg;
∙ 2002-09-23;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02245867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69984
∙ GRAVOL CHEWABLES
∙ dimenhydrinate 50 mg;
∙ 2012-11-14;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02384132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86988
∙ DIMENHYDRINATE CAPSULES
∙ dimenhydrinate 50 mg;
∙ 2014-07-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02407396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89209
∙ GAVISCON NAUSEA
∙ dimenhydrinate 50 mg;
∙ 2020-02-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02490528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98056
∙ ANTI-NAUSEANT LIQUID GELS
∙ dimenhydrinate 50 mg;
∙ 2020-08-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02493004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98298
∙ GRAVOL IM
∙ dimenhydrinate 50 mg / ml;
∙ 1953-12-31;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Ethical | Spécialité Médicale;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 00013579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=197
∙ DIMENHYDRINATE INJ 50MG USP
∙ dimenhydrinate 50 mg / ml;
∙ 1973-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00392537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3397
∙ DIMENHYDRINATE INJECTION USP
∙ dimenhydrinate 50 mg / ml;
∙ 2016-01-28;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Ethical | Spécialité Médicale;
∙ TELIGENT OU;
∙ DIN: 02428954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91339
∙ DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE
∙ dimenhydrinate 50 mg / ml;
∙ 2016-01-28;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 56:22.08 – ANTIHISTAMINES;
∙ Ethical | Spécialité Médicale;
∙ TELIGENT OU;
∙ DIN: 02435241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91952
∙ PROSHIELD PLUS
∙ dimethicone 1 % / w/w;
∙ 2005-02-11;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ SMITH & NEPHEW INC;
∙ DIN: 02256975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74220
∙ CAVILON DURABLE BARRIER CREAM
∙ dimethicone 1.3 % / w/w;
∙ 2017-04-28;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02455838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94265
∙ BAZA CLEANSE & PROTECT
∙ dimethicone 2 % / w/w;
∙ 2002-06-01;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ COLOPLAST A/S;
∙ DIN: 02243966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67909
∙ COMFORT SHIELD
∙ dimethicone 3 %;
∙ 2004-12-10;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ SAGE PRODUCTS LLC;
∙ DIN: 02245871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69988
∙ DIMETHICONE PROTECTANT
∙ dimethicone 5.0 % / w/w;
∙ 2008-05-30;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ SMITH & NEPHEW INC;
∙ DIN: 02301725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78703
∙ NYDA
∙ dimethicone 50 %;
∙ 2012-01-06;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.12 – SCABICIDES AND PEDICULICIDES;
∙ Otc | En Vente Libre;
∙ G POHL-BOSKAMP GMBH & CO KG;
∙ DIN: 02373785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85900
∙ SWEEN 24
∙ dimethicone 6 % / w/w;
∙ 2004-11-29;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ COLOPLAST A/S;
∙ DIN: 02250322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73513
∙ TECFIDERA
∙ dimethyl fumarate 120 mg;
∙ 2013-04-12;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ BIOGEN CANADA INC;
∙ DIN: 02404508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88926
∙ TECFIDERA
∙ dimethyl fumarate 240 mg;
∙ 2014-02-04;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ BIOGEN CANADA INC;
∙ DIN: 02420201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90480
∙ RIMSO-50
∙ dimethyl sulfoxide 500 mg / g;
∙ 1980-12-31;
∙ Intravesical | Intravésicale;
∙ Solution | Solution;
∙ 92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 00493392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3769
∙ PROSTIN E2 TABLETS
∙ dinoprostone 0.5 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00400688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2684
∙ PREPIDIL GEL
∙ dinoprostone 0.5 mg / 2.5 ml;
∙ 1990-12-31;
∙ Intracervical | Intracervicale;
∙ Gel | Gel;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00860786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10492
∙ PROSTIN E2 VAGINAL GEL
∙ dinoprostone 1 mg / 3 g;
∙ 1991-12-31;
∙ Vaginal | Vaginale;
∙ Gel | Gel;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 01919679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11830
∙ CERVIDIL
∙ dinoprostone 10 mg / insert;
∙ 1997-06-17;
∙ Vaginal | Vaginale;
∙ Insert | Insert;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02231047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50327
∙ PROSTIN E2 VAGINAL GEL
∙ dinoprostone 2 mg / 3 g;
∙ 1991-12-31;
∙ Vaginal | Vaginale;
∙ Gel | Gel;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 01919687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11831
∙ UNITUXIN
∙ dinutuximab 3.5 mg / ml;
∙ 2019-05-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ UNITED THERAPEUTICS CORPORATION;
∙ DIN: 02483076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97347
∙ CHILDREN’S BENADRYL ALLERGY CHEWABLES
∙ diphenhydramine hydrochloride 12.5 mg;
∙ 1998-03-06;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02061287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27547
∙ BENADRYL ALLERGY LIQUID
∙ diphenhydramine hydrochloride 12.5 mg / 5 ml;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02019736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15516
∙ BENYLIN SLEEP TIME
∙ diphenhydramine hydrochloride 12.5 mg / 5 ml;
∙ 2012-08-31;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02248859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73231
∙ DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP
∙ diphenhydramine hydrochloride 12.5 mg / 5 ml;
∙ 2009-01-30;
∙ Oral | Orale;
∙ Elixir | Élixir;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02298503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78380
∙ ALLERGY FORMULA
∙ diphenhydramine hydrochloride 12.5 mg / 5 ml;
∙ 2018-09-10;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02465108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95330
∙ BENADRYL CREAM 2%
∙ diphenhydramine hydrochloride 2 %;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02019701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14257
∙ ANTI-ITCH CREAM
∙ diphenhydramine hydrochloride 2 %;
∙ 2007-12-20;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02247560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71812
∙ PDP-DIPHENHYDRAMINE
∙ diphenhydramine hydrochloride 25 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00757683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10874
∙ ALLERGY TABLETS 25MG
∙ diphenhydramine hydrochloride 25 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 01949454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13447
∙ BENADRYL ALLERGY
∙ diphenhydramine hydrochloride 25 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02017849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13782
∙ ALLERNIX
∙ diphenhydramine hydrochloride 25 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02097583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17794
∙ ALLERGY FORMULA CAPLETS
∙ diphenhydramine hydrochloride 25 mg;
∙ 1997-09-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02141728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31477
∙ ALLERGY FORMULA
∙ diphenhydramine hydrochloride 25 mg;
∙ 1997-04-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02229492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47391
∙ SLEEP-EZE REGULAR STRENGTH CAPLETS
∙ diphenhydramine hydrochloride 25 mg;
∙ 1997-11-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02229960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48414
∙ NADRYL 25MG
∙ diphenhydramine hydrochloride 25 mg;
∙ 2002-02-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02239029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62481
∙ JAMP DIPHENHYDRAMINE 25 MG
∙ diphenhydramine hydrochloride 25 mg;
∙ 2005-09-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02257548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74279
∙ NIGHTTIME SLEEP AID
∙ diphenhydramine hydrochloride 25 mg;
∙ 2014-01-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02297701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78305
∙ BENADRYL ALLERGY LIQUIGELS
∙ diphenhydramine hydrochloride 25 mg;
∙ 2008-05-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02304252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78954
∙ ALLERGY FORMULA LIQUID CAPSULES
∙ diphenhydramine hydrochloride 25 mg;
∙ 2008-07-11;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02306352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79190
∙ SLEEP-EZE
∙ diphenhydramine hydrochloride 25 mg;
∙ 2010-08-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.00 – FIRST GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ PRESTIGE BRANDS INC;
∙ DIN: 02348608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83395
∙ REGULAR STRENGTH SLEEP AID
∙ diphenhydramine hydrochloride 25 mg;
∙ 2011-03-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02365685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85056
∙ ZZZQUIL
∙ diphenhydramine hydrochloride 25 mg;
∙ 2013-02-12;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02383268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86902
∙ ALLERGY FORMULA CAPLETS
∙ diphenhydramine hydrochloride 25 mg;
∙ 2018-11-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02479710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97036
∙ DORMIPHEN EXTRA-FORT CAPSULE
∙ diphenhydramine hydrochloride 50 mg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE LALCO INC.;
∙ DIN: 00489867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3775
∙ EXTRA STRENGTH NYTOL TAB 50MG
∙ diphenhydramine hydrochloride 50 mg;
∙ 1983-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 00583332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5187
∙ PDP-DIPHENHYDRAMINE EXTRA STRENGTH/ EXTRA FORT
∙ diphenhydramine hydrochloride 50 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00757691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10875
∙ NYTOL EXTRA STRENGTH SLEEP AID CAPLET 50MG
∙ diphenhydramine hydrochloride 50 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 01934414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11762
∙ UNISOM
∙ diphenhydramine hydrochloride 50 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 01946986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12743
∙ ALLERNIX EXTRA STRENGTH
∙ diphenhydramine hydrochloride 50 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02097575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17781
∙ SLEEP AID EXTRA STRENGTH TAB 50MG
∙ diphenhydramine hydrochloride 50 mg;
∙ 1997-03-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 01991086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=24750
∙ UNISOM SLEEPGELS EXTRA STRENGTH
∙ diphenhydramine hydrochloride 50 mg;
∙ 1996-09-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 02061597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27528
∙ SLEEP-EZE EXTRA STRENGTH CAPLETS
∙ diphenhydramine hydrochloride 50 mg;
∙ 1997-11-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02229959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48413
∙ ALLERGY TABLETS EXTRA STRENGTH
∙ diphenhydramine hydrochloride 50 mg;
∙ 1997-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02230398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49235
∙ SLEEP AID
∙ diphenhydramine hydrochloride 50 mg;
∙ 1997-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02230485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49476
∙ EXTRA STRENGTH NYTOL QUICKGELS
∙ diphenhydramine hydrochloride 50 mg;
∙ 1999-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02237169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60487
∙ DORMIPHEN EXTRA-FORT COMPRIME
∙ diphenhydramine hydrochloride 50 mg;
∙ 1998-06-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE LALCO INC.;
∙ DIN: 02237789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61146
∙ SLEEP-EZE EXTRA STRENGTH GELCAPS
∙ diphenhydramine hydrochloride 50 mg;
∙ 1999-12-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02238644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62073
∙ EXTRA STRENGTH BENADRYL ALLERGY NIGHTTIME
∙ diphenhydramine hydrochloride 50 mg;
∙ 1999-04-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02239138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62594
∙ SLEEP AID LIQUID FASTGELS
∙ diphenhydramine hydrochloride 50 mg;
∙ 2001-09-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02244203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68166
∙ JAMP DIPHENHYDRAMINE 50 MG
∙ diphenhydramine hydrochloride 50 mg;
∙ 2005-09-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02257556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74280
∙ EXTRA STRENGTH ALLERGY FORMULA LIQUID CAPSULES
∙ diphenhydramine hydrochloride 50 mg;
∙ 2009-11-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02321270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80667
∙ EXTRA STRENGTH DORMEX CAPSULES
∙ diphenhydramine hydrochloride 50 mg;
∙ 2013-11-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02409224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89394
∙ EXTRA STRENGTH DORMEX CAPLETS
∙ diphenhydramine hydrochloride 50 mg;
∙ 2013-11-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02409259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89397
∙ EXTRA STRENGTH BENADRYL ALLERGY
∙ diphenhydramine hydrochloride 50 mg;
∙ 2018-03-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02470144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95910
∙ SLEEP-EZE EXTRA STRENGTH MINIS
∙ diphenhydramine hydrochloride 50 mg;
∙ 2018-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02478757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96950
∙ DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP
∙ diphenhydramine hydrochloride 50 mg / ml;
∙ 1983-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00596612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5430
∙ DIPHENIST 50MG/ML
∙ diphenhydramine hydrochloride 50 mg / ml;
∙ 1997-10-28;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Ethical | Spécialité Médicale;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02219336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37198
∙ DIPHENHYDRAMINE HYDROCHLORIDE INJECTION
∙ diphenhydramine hydrochloride 50 mg / ml;
∙ 2012-02-17;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02369567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85449
∙ ZZZQUIL LIQUID
∙ diphenhydramine hydrochloride 50 mg / 30 ml;
∙ 2014-08-15;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02419769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90439
∙ NIGHTTIME SLEEP AID LIQUID
∙ diphenhydramine hydrochloride 50 mg / 30 ml;
∙ 2015-05-13;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.00 – FIRST GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02427427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91195
∙ SLEEP-EZE EZE-LIQUID
∙ diphenhydramine hydrochloride 50 mg / 30 ml;
∙ 2015-03-30;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02432129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91657
∙ NIGHTTIME SLEEP AID
∙ diphenhydramine hydrochloride 50 mg / 30 ml;
∙ 2018-06-14;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02464683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95281
∙ SLEEP-EZE EZE-FREE
∙ diphenhydramine hydrochloride 50 mg / 30 ml;
∙ 2018-12-03;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MEDTECH PRODUCTS INC;
∙ DIN: 02474867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96508
∙ CHILDREN’S BENADRYL ALLERGY LIQUID
∙ diphenhydramine hydrochloride 6.25 mg / 5 ml;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02019698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15880
∙ BENYLIN FOR CHILDREN COUGH NIGHT
∙ diphenhydramine hydrochloride 6.25 mg / 5 ml;
∙ 2013-01-28;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02248858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73230
∙ CHILDREN’S CLEAR ALLERGY FORMULA
∙ diphenhydramine hydrochloride 6.25 mg / 5 ml;
∙ 2020-04-24;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02478242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96896
∙ APO-DIPYRIDAMOLE
∙ dipyridamole 25 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00895644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11034
∙ PERSANTINE
∙ dipyridamole 5 mg / ml;
∙ 1986-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE;
∙ DIN: 00637734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6720
∙ DIPYRIDAMOLE INJECTION, USP
∙ dipyridamole 5 mg / ml;
∙ 2002-04-23;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02244475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68448
∙ APO-DIPYRIDAMOLE
∙ dipyridamole 50 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00895652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11035
∙ RYTHMODAN
∙ disopyramide 100 mg;
∙ 2003-09-12;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:04.04.04 – CLASS IA ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02224801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37379
∙ DOBUTAMINE INJECTION USP
∙ dobutamine (dobutamine hydrochloride) 12.5 mg / ml;
∙ 2000-10-02;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02242010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65680
∙ DOBUTAMINE INJECTION USP
∙ dobutamine (dobutamine hydrochloride) 12.5 mg / ml;
∙ 2017-12-14;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02462729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95055
∙ DOBUTAMINE INJECTION USP
∙ dobutamine (dobutamine hydrochloride) 250 mg / 20 ml;
∙ 1996-10-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02210401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43041
∙ DOCETAXEL INJECTION USP
∙ docetaxel 10 mg / ml;
∙ 2011-03-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02361957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84699
∙ DOCETAXEL INJECTION
∙ docetaxel 10 mg / ml;
∙ 2016-06-02;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02439336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92370
∙ DOCETAXEL INJECTION
∙ docetaxel 20 mg / ml;
∙ 2015-02-27;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02437031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92134
∙ DOCETAXEL INJECTION
∙ docetaxel 20 mg / ml;
∙ 2017-10-17;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BIOLYSE PHARMA CORPORATION;
∙ DIN: 02458020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94508
∙ ABREVA
∙ docosanol 10 %;
∙ 2005-08-15;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.06 – ANTIVIRALS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02245677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69777
∙ JAMP-DOCUSATE CALCIUM
∙ docusate calcium 240 mg;
∙ 2006-10-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02283255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76888
∙ COLACE
∙ docusate sodium 10 mg / ml;
∙ 1997-04-01;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02090163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28453
∙ SELAX CAP 100MG
∙ docusate sodium 100 mg;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ ODAN LABORATORIES LTD;
∙ DIN: 00514888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6258
∙ PMS-DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 1986-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 00703494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7365
∙ TARO-DOCUSATE
∙ docusate sodium 100 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00716731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8974
∙ SOFLAX CAPSULES 100MG
∙ docusate sodium 100 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 01994344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14487
∙ COLACE CAPSULES
∙ docusate sodium 100 mg;
∙ 1997-07-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02106256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=29540
∙ STOOL SOFTENER
∙ docusate sodium 100 mg;
∙ 1998-08-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02232969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52463
∙ JAMP-DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 2004-06-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02245946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70070
∙ SANDOZ DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 2006-11-20;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02247385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71630
∙ STOOL SOFTENER
∙ docusate sodium 100 mg;
∙ 2007-10-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02281031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76671
∙ DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 2009-06-12;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PRO DOC LIMITEE;
∙ DIN: 02326086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81142
∙ STOOL SOFTENER
∙ docusate sodium 100 mg;
∙ 2011-01-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02357305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84243
∙ JAMP DOCUSATE S OBLONG
∙ docusate sodium 100 mg;
∙ 2016-04-12;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02376121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86158
∙ DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 2014-07-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ SANIS HEALTH INC;
∙ DIN: 02426838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91138
∙ M-DOCUSATE SODIUM 100 MG
∙ docusate sodium 100 mg;
∙ 2019-09-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ MANTRA PHARMA INC;
∙ DIN: 02437317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92166
∙ ALTA-DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 2018-05-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ ALTAMED PHARMA;
∙ DIN: 02465329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95352
∙ COLACE CLEAR
∙ docusate sodium 100 mg;
∙ 2019-03-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02484226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97454
∙ AG-DOCUSATE SODIUM
∙ docusate sodium 100 mg;
∙ 2021-06-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ ANGITA PHARMA INC.;
∙ DIN: 02500019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98973
∙ PMS-DOCUSATE SODIUM
∙ docusate sodium 20 mg / 5 ml;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 00703508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7366
∙ RATIO-DOCUSATE SODIUM
∙ docusate sodium 20 mg / 5 ml;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00870226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11520
∙ SOFLAX SYRUP 4MG/ML
∙ docusate sodium 20 mg / 5 ml;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02006758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18776
∙ COLACE SYRUP
∙ docusate sodium 20 mg / 5 ml;
∙ 1997-04-01;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ BOYD PHARMACEUTICALS INC.;
∙ DIN: 02086018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28280
∙ SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML
∙ docusate sodium 20 mg / 5 ml;
∙ 1998-09-02;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 02238283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61679
∙ PMS-DOCUSATE SODIUM
∙ docusate sodium 200 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 00765104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10975
∙ SOFLAX
∙ docusate sodium 200 mg;
∙ 1998-04-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02029529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26561
∙ TIVICAY
∙ dolutegravir (dolutegravir sodium) 10 mg;
∙ 2017-06-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.92 – MISCELLANEOUS ANTIRETROVIRALS*;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02461218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94871
∙ TIVICAY
∙ dolutegravir (dolutegravir sodium) 25 mg;
∙ 2017-06-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.92 – MISCELLANEOUS ANTIRETROVIRALS*;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02461226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94872
∙ TIVICAY
∙ dolutegravir (dolutegravir sodium) 50 mg;
∙ 2013-11-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.92 – MISCELLANEOUS ANTIRETROVIRALS*;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02414945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89957
∙ TEVA-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01912070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13180
∙ APO-DOMPERIDONE – TAB 10MG
∙ domperidone (domperidone maleate) 10 mg;
∙ 1997-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02103613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43813
∙ DOMPERIDONE-10
∙ domperidone (domperidone maleate) 10 mg;
∙ 1998-07-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02236857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60147
∙ DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 1998-09-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02238341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61748
∙ RAN-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2005-07-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02268078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75346
∙ DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2010-05-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02350440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83565
∙ JAMP-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2011-10-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02369206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85414
∙ MAR-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2014-01-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02403870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88864
∙ BIO-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2016-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02445034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93024
∙ PRIVA-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2017-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02445328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93055
∙ PRZ-DOMPERIDONE
∙ domperidone (domperidone maleate) 10 mg;
∙ 2018-04-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:32.00 – PROKINETIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMARIS CANADA INC;
∙ DIN: 02462834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95069
∙ PMS-DONEPEZIL
∙ donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02322358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80780
∙ APO-DONEPEZIL
∙ donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg;
∙ 2014-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02362279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84729
∙ ACT DONEPEZIL ODT
∙ donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02397625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88256
∙ PMS-DONEPEZIL
∙ donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02322331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80779
∙ APO-DONEPEZIL
∙ donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02362260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84728
∙ ACT DONEPEZIL ODT
∙ donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02397617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88255
∙ ARICEPT
∙ donepezil hydrochloride 10 mg;
∙ 1997-08-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02232044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51492
∙ ARICEPT RDT
∙ donepezil hydrochloride 10 mg;
∙ 2006-01-02;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02269465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75484
∙ SANDOZ DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02328682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81419
∙ TEVA-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02340615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82619
∙ TARO-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02381516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86736
∙ AURO-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02400588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88537
∙ MAR-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2014-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02402106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88697
∙ ACH-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02402653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88750
∙ MINT-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2019-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02408619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89335
∙ BIO-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02412861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89757
∙ DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2013-12-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02416425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90098
∙ JAMP-DONEPEZIL TABLETS
∙ donepezil hydrochloride 10 mg;
∙ 2014-09-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02416956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90158
∙ DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2014-02-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02420600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90517
∙ DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2018-03-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02426854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91140
∙ AG-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2021-05-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02432692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91712
∙ NAT-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02439565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92398
∙ PRIVA-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2020-12-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02446677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93211
∙ M-DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2017-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02467461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95584
∙ DONEPEZIL
∙ donepezil hydrochloride 10 mg;
∙ 2018-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02475286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96564
∙ ARICEPT
∙ donepezil hydrochloride 5 mg;
∙ 1997-08-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02232043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51491
∙ ARICEPT RDT
∙ donepezil hydrochloride 5 mg;
∙ 2006-01-02;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02269457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75483
∙ SANDOZ DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02328666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81417
∙ TEVA-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02340607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82618
∙ TARO-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02381508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86735
∙ AURO-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02400561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88536
∙ MAR-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2014-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02402092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88696
∙ ACH-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02402645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88749
∙ MINT-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2019-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02408600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89334
∙ BIO-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02412853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89756
∙ DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2013-12-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02416417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90097
∙ JAMP-DONEPEZIL TABLETS
∙ donepezil hydrochloride 5 mg;
∙ 2014-09-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02416948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90157
∙ DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2014-02-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02420597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90516
∙ DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2018-03-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02426846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91139
∙ AG-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2021-05-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02432684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91711
∙ NAT-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02439557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92397
∙ PRIVA-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2020-12-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02446669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93210
∙ M-DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2017-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02467453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95583
∙ DONEPEZIL
∙ donepezil hydrochloride 5 mg;
∙ 2018-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02475278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96563
∙ PIFELTRO
∙ doravirine 100 mg;
∙ 2018-11-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02481545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97199
∙ PULMOZYME 1MG/ML
∙ dornase alfa 1 mg / ml;
∙ 1994-12-31;
∙ Inhalation | Inhalation;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02046733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15483
∙ TRUSOPT
∙ dorzolamide (dorzolamide hydrochloride) 2 %;
∙ 1996-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ ELVIUM LIFE SCIENCES;
∙ DIN: 02216205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20083
∙ TRUSOPT
∙ dorzolamide (dorzolamide hydrochloride) 2 %;
∙ 2006-02-01;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ ELVIUM LIFE SCIENCES;
∙ DIN: 02269090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75449
∙ SANDOZ DORZOLAMIDE
∙ dorzolamide (dorzolamide hydrochloride) 2 %;
∙ 2010-10-25;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02316307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80181
∙ JAMP-DORZOLAMIDE
∙ dorzolamide (dorzolamide hydrochloride) 2 % / w/v;
∙ 2019-12-24;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02453347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93987
∙ TEVA-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 1 mg;
∙ 2000-09-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66535
∙ JAMP-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 1 mg;
∙ 2020-05-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02489937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98001
∙ APO-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 1 mg / tab;
∙ 1999-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02240588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64159
∙ TEVA-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 2 mg;
∙ 2000-09-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66536
∙ JAMP-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 2 mg;
∙ 2020-05-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02489945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98002
∙ APO-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 2 mg / tab;
∙ 1999-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02240589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64160
∙ TEVA-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 4 mg;
∙ 2000-09-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02242730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66537
∙ JAMP-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 4 mg;
∙ 2020-05-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02489953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98003
∙ APO-DOXAZOSIN
∙ doxazosin (doxazosin mesylate) 4 mg / tab;
∙ 1999-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02240590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64161
∙ SINEQUAN
∙ doxepin (doxepin hydrochloride) 10 mg;
∙ 1970-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00024325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=944
∙ SINEQUAN
∙ doxepin (doxepin hydrochloride) 100 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00326925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2049
∙ SINEQUAN
∙ doxepin (doxepin hydrochloride) 25 mg;
∙ 1970-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00024333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=945
∙ SILENOR
∙ doxepin (doxepin hydrochloride) 3.00 mg;
∙ 2013-01-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02398257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88319
∙ SINEQUAN
∙ doxepin (doxepin hydrochloride) 50 mg;
∙ 1970-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00024341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=946
∙ SILENOR
∙ doxepin (doxepin hydrochloride) 6.00 mg;
∙ 2013-01-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02398265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88320
∙ SINEQUAN
∙ doxepin (doxepin hydrochloride) 75 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00400750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2780
∙ DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
∙ doxorubicin hydrochloride 10 mg / vial;
∙ 1998-03-12;
∙ Intravenous , Intravesical | Intraveineuse , Intravésicale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02194457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42943
∙ DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
∙ doxorubicin hydrochloride 150 mg / vial;
∙ 1997-05-08;
∙ Intravenous , Intravesical | Intraveineuse , Intravésicale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02194473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42945
∙ CAELYX
∙ doxorubicin hydrochloride 2 mg / ml;
∙ 1998-08-19;
∙ Intravenous | Intraveineuse;
∙ Suspension | Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02238389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61804
∙ DOXORUBICIN INJECTION, BP
∙ doxorubicin hydrochloride 2 mg / ml;
∙ 2014-12-16;
∙ Intravenous , Intravesical | Intraveineuse , Intravésicale;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02381982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86785
∙ DOXORUBICIN HYDROCHLORIDE INJECTION
∙ doxorubicin hydrochloride 2 mg / ml;
∙ 2014-02-27;
∙ Intravenous , Intravesical | Intraveineuse , Intravésicale;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02409275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89399
∙ DOXORUBICIN
∙ doxorubicin hydrochloride 2 mg / ml;
∙ 2014-05-21;
∙ Intravenous , Intravesical | Intraveineuse , Intravésicale;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02410397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89506
∙ TARO-DOXORUBICIN LIPOSOMAL
∙ doxorubicin hydrochloride 2 mg / ml;
∙ 2020-05-19;
∙ Intravenous | Intraveineuse;
∙ Suspension | Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02493020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98300
∙ DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
∙ doxorubicin hydrochloride 50 mg / vial;
∙ 1997-07-30;
∙ Intravenous , Intravesical | Intraveineuse , Intravésicale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02194465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42944
∙ APO-DOXY CAP 100MG
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00740713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7627
∙ DOXYCIN TAB 100MG
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 00860751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10024
∙ TEVA-DOXYCYCLINE
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00725250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10117
∙ APO-DOXY TABS 100MG
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00874256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10383
∙ DOXYTAB
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00887064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10897
∙ TEVA-DOXYCYCLINE
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02158574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18421
∙ DOXYCYCLINE CAPSULES
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83642
∙ DOXYCYCLINE TABLETS
∙ doxycycline (doxycycline hyclate) 100 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83643
∙ PERIOSTAT
∙ doxycycline (doxycycline hyclate) 20 mg;
∙ 2003-09-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02247104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71343
∙ ATRIDOX
∙ doxycycline (doxycycline hyclate) 8.8 % / w/w;
∙ 2001-01-31;
∙ Subgingival | Sous-Gingivale;
∙ Gel (Controlled-Release) | Gel (À Libération Prolongée);
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ DEN-MAT HOLDINGS, LLC;
∙ DIN: 02242473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66197
∙ APPRILON
∙ doxycycline (doxycycline monohydrate) 40 mg;
∙ 2012-11-29;
∙ Oral | Orale;
∙ Capsule (Immediate And Delayed Release) | Capsule (À Libération Immédiate Et Retardée);
∙ 08:12.24 – TETRACYCLINES;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02375885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86128
∙ MULTAQ
∙ dronedarone (dronedarone hydrochloride) 400 mg;
∙ 2009-09-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02330989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81672
∙ TRULICITY
∙ dulaglutide 0.75 mg / 0.5 ml;
∙ 2016-01-08;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:20.06 – INCRETIN MIMETICS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02448599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93430
∙ TRULICITY
∙ dulaglutide 1.5 mg / 0.5 ml;
∙ 2015-11-24;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:20.06 – INCRETIN MIMETICS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02448602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93431
∙ CYMBALTA
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2008-01-18;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02301482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78681
∙ PMS-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02429446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91389
∙ AURO-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02436647
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92097
∙ DULOXETINE DR
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02437082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92139
∙ RAN-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02438259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92262
∙ MINT-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02438984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92335
∙ SANDOZ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02439948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92433
∙ APO-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02440423
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92479
∙ MAR-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-10;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02446081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93136
∙ RIVA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02451077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93732
∙ JAMP-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02451913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93831
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02452650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93902
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2016-05-05;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02453630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94019
∙ TEVA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2020-04-24;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02456753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94374
∙ M-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2018-06-26;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02473208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96254
∙ AG-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2018-07-19;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02475308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96567
∙ NRA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2019-03-06;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02482126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97243
∙ PRIVA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2020-05-07;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98047
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2019-09-10;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02490889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98092
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 30 mg;
∙ 2020-04-06;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02495082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98503
∙ CYMBALTA
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2008-01-18;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02301490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78682
∙ PMS-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02429454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91391
∙ AURO-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02436655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92098
∙ DULOXETINE DR
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02437090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92140
∙ RAN-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02438267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92263
∙ MINT-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02438992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92336
∙ SANDOZ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02439956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92434
∙ APO-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02440431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92480
∙ MAR-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-10;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02446103
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93137
∙ RIVA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-12;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02451085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93733
∙ JAMP-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02451921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93832
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02452669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93903
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2016-05-05;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02453649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94020
∙ TEVA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2020-04-24;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02456761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94375
∙ M-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2018-09-26;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02473216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96255
∙ AG-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2018-07-19;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02475316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96568
∙ NRA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2019-03-06;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02482134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97244
∙ PRIVA-DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2020-05-07;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98046
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2019-09-10;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02490897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98093
∙ DULOXETINE
∙ duloxetine (duloxetine hydrochloride) 60 mg;
∙ 2020-04-06;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02495090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98504
∙ DUPIXENT
∙ dupilumab 150 mg / ml;
∙ 2018-02-06;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02470365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95935
∙ DUPIXENT
∙ dupilumab 150 mg / ml;
∙ 2021-05-27;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02510049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99930
∙ DUPIXENT
∙ dupilumab 200 mg / 1.14 ml;
∙ 2019-11-29;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02492504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98251
∙ IMFINZI
∙ durvalumab 50 mg / ml;
∙ 2017-11-20;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02468816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95736
∙ AVODART
∙ dutasteride 0.5 mg;
∙ 2003-11-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02247813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72107
∙ APO-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-07-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02404206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88899
∙ TEVA-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-07-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02408287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89301
∙ ACT DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-09-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02412691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89736
∙ MED-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-10-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ GENERIC MEDICAL PARTNERS INC;
∙ DIN: 02416298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90086
∙ DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-07-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02421712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90637
∙ RIVA-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-09-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02427753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91226
∙ MINT-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-09-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02428873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91334
∙ DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2014-10-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02429012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91345
∙ DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2015-07-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02443058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92760
∙ AURO-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2018-06-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02469308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95804
∙ JAMP DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2019-11-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02484870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97515
∙ PRIVA-DUTASTERIDE
∙ dutasteride 0.5 mg;
∙ 2020-06-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98062
∙ SOLIRIS
∙ eculizumab 10 mg / ml;
∙ 2009-05-25;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 92:32.00 – COMPLEMENT INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ALEXION PHARMA GMBH;
∙ DIN: 02322285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80774
∙ RADICAVA
∙ edaravone 30 mg / 100 ml;
∙ 2019-10-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ MITSUBISHI TANABE PHARMA CORPORATION;
∙ DIN: 02475472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96585
∙ LIXIANA
∙ edoxaban (edoxaban tosylate monohydrate) 15 mg;
∙ 2017-04-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02458640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94579
∙ LIXIANA
∙ edoxaban (edoxaban tosylate monohydrate) 30 mg;
∙ 2017-04-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02458659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94580
∙ LIXIANA
∙ edoxaban (edoxaban tosylate monohydrate) 60 mg;
∙ 2017-04-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02458667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94581
∙ SUSTIVA 200MG
∙ efavirenz 200 mg;
∙ 1999-03-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02239888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63376
∙ SUSTIVA 50MG
∙ efavirenz 50 mg;
∙ 1999-03-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02239886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63374
∙ SUSTIVA TABLETS
∙ efavirenz 600 mg;
∙ 2002-11-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02246045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70176
∙ MYLAN-EFAVIRENZ
∙ efavirenz 600 mg;
∙ 2013-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02381524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86737
∙ TEVA-EFAVIRENZ
∙ efavirenz 600 mg;
∙ 2013-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02389762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87524
∙ AURO-EFAVIRENZ
∙ efavirenz 600 mg;
∙ 2014-03-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02418428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90299
∙ JAMP-EFAVIRENZ
∙ efavirenz 600 mg;
∙ 2019-06-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02458233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94530
∙ JUBLIA
∙ efinaconazole 10 % / w/w;
∙ 2014-07-21;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.08.08 – AZOLES;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02413388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89805
∙ VANIQA
∙ eflornithine hydrochloride 13.9 % / w/w;
∙ 2005-11-01;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ CIPHER PHARMACEUTICALS INC;
∙ DIN: 02243837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67778
∙ ORILISSA
∙ elagolix (elagolix sodium) 150 mg;
∙ 2018-10-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02481332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97182
∙ ORILISSA
∙ elagolix (elagolix sodium) 200 mg;
∙ 2019-05-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02481340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97183
∙ RELPAX
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2004-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02256290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74152
∙ GD-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2012-10-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02342235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82774
∙ TEVA-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2013-12-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02382091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86796
∙ APO-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2013-09-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02386054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87164
∙ AURO-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2019-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02479451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97013
∙ ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2019-07-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02489961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98004
∙ ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 20 mg;
∙ 2021-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02511266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100048
∙ RELPAX
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2004-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02256304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74153
∙ GD-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2012-10-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02342243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82775
∙ TEVA-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2013-12-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02382105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86797
∙ APO-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2013-09-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02386062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87165
∙ AURO-ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2019-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02479478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97014
∙ ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2019-07-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02489988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98005
∙ ELETRIPTAN
∙ eletriptan (eletriptan hydrobromide) 40 mg;
∙ 2021-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02511274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100049
∙ CERDELGA
∙ eliglustat (eliglustat tartrate) 84 mg;
∙ 2017-07-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC;
∙ DIN: 02463261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95117
∙ VIMIZIM
∙ elosulfase alfa 1 mg / ml;
∙ 2014-08-27;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BIOMARIN INTERNATIONAL LIMITED;
∙ DIN: 02427184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91171
∙ REVOLADE
∙ eltrombopag (eltrombopag olamine) 25 mg;
∙ 2011-04-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02361825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84687
∙ REVOLADE
∙ eltrombopag (eltrombopag olamine) 50 mg;
∙ 2011-04-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02361833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84688
∙ VIBERZI
∙ eluxadoline 100 mg;
∙ 2017-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:92.00 – MISCELLANEOUS GI DRUGS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02460904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94841
∙ VIBERZI
∙ eluxadoline 75 mg;
∙ 2017-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:92.00 – MISCELLANEOUS GI DRUGS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02460890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94840
∙ HEMLIBRA
∙ emicizumab 105 mg / 0.7 ml;
∙ 2019-02-21;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02479656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97032
∙ HEMLIBRA
∙ emicizumab 150 mg / ml;
∙ 2018-11-27;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02479664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97033
∙ HEMLIBRA
∙ emicizumab 30 mg / 1 ml;
∙ 2018-10-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02479621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97030
∙ HEMLIBRA
∙ emicizumab 60 mg / 0.4 ml;
∙ 2018-10-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02479648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97031
∙ JARDIANCE
∙ empagliflozin 10 mg;
∙ 2015-08-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02443937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92871
∙ JARDIANCE
∙ empagliflozin 25 mg;
∙ 2015-08-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02443945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92872
∙ APO-ENALAPRIL TAB 10MG
∙ enalapril maleate 10 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02019892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14387
∙ PRO-ENALAPRIL – 10
∙ enalapril maleate 10 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02311429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79700
∙ MAR-ENALAPRIL
∙ enalapril maleate 10 mg;
∙ 2019-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02444771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92998
∙ JAMP ENALAPRIL
∙ enalapril maleate 10 mg;
∙ 2019-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02474808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96499
∙ APO-ENALAPRIL TAB 2.5MG
∙ enalapril maleate 2.5 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02020025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14385
∙ PRO-ENALAPRIL – 2.5
∙ enalapril maleate 2.5 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02311402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79698
∙ MAR-ENALAPRIL
∙ enalapril maleate 2.5 mg;
∙ 2019-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02459450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94669
∙ JAMP ENALAPRIL
∙ enalapril maleate 2.5 mg;
∙ 2019-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02474786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96497
∙ APO-ENALAPRIL TAB 20MG
∙ enalapril maleate 20 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02019906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14388
∙ PRO-ENALAPRIL – 20
∙ enalapril maleate 20 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02311437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79701
∙ MAR-ENALAPRIL
∙ enalapril maleate 20 mg;
∙ 2019-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02444798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92999
∙ JAMP ENALAPRIL
∙ enalapril maleate 20 mg;
∙ 2019-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02474816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96500
∙ APO-ENALAPRIL TAB 5MG
∙ enalapril maleate 5 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02019884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14386
∙ PRO-ENALAPRIL – 5
∙ enalapril maleate 5 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02311410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79699
∙ MAR-ENALAPRIL
∙ enalapril maleate 5 mg;
∙ 2019-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02459469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94670
∙ JAMP ENALAPRIL
∙ enalapril maleate 5 mg;
∙ 2019-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02474794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96498
∙ VASOTEC
∙ enalapril sodium (enalapril maleate) 16 mg;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00670928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8103
∙ ACT ENALAPRIL
∙ enalapril sodium (enalapril maleate) 16 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02291908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77727
∙ ENALAPRIL
∙ enalapril sodium (enalapril maleate) 16 mg;
∙ 2015-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92751
∙ ACT ENALAPRIL
∙ enalapril sodium (enalapril maleate) 2 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02291878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77724
∙ ENALAPRIL
∙ enalapril sodium (enalapril maleate) 2 mg;
∙ 2015-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92748
∙ VASOTEC
∙ enalapril sodium (enalapril maleate) 4 mg;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00708879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8111
∙ ACT ENALAPRIL
∙ enalapril sodium (enalapril maleate) 4 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02291886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77725
∙ ENALAPRIL
∙ enalapril sodium (enalapril maleate) 4 mg;
∙ 2015-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92749
∙ VASOTEC
∙ enalapril sodium (enalapril maleate) 8 mg;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00670901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8102
∙ ACT ENALAPRIL
∙ enalapril sodium (enalapril maleate) 8 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02291894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77726
∙ ENALAPRIL
∙ enalapril sodium (enalapril maleate) 8 mg;
∙ 2015-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92750
∙ SANDOZ ENALAPRIL
∙ enalapril sodium 16 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78531
∙ RAN-ENALAPRIL
∙ enalapril sodium 16 mg;
∙ 2010-08-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02352265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83750
∙ ENALAPRIL
∙ enalapril sodium 16 mg;
∙ 2013-02-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02400685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88546
∙ SANDOZ ENALAPRIL
∙ enalapril sodium 2 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78528
∙ RAN-ENALAPRIL
∙ enalapril sodium 2 mg;
∙ 2010-08-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02352230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83747
∙ SANDOZ ENALAPRIL
∙ enalapril sodium 4 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78529
∙ RAN-ENALAPRIL
∙ enalapril sodium 4 mg;
∙ 2010-08-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02352249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83748
∙ SANDOZ ENALAPRIL
∙ enalapril sodium 8 mg;
∙ 2007-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02299968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78530
∙ RAN-ENALAPRIL
∙ enalapril sodium 8 mg;
∙ 2010-08-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02352257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83749
∙ ENALAPRIL
∙ enalapril sodium 8 mg;
∙ 2013-02-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02400677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88545
∙ VASOTEC IV
∙ enalaprilat 1.25 mg / ml;
∙ 1992-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 01923846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12650
∙ ENALAPRILAT INJECTION USP
∙ enalaprilat 1.25 mg / ml;
∙ 2012-09-10;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02388499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87402
∙ IDHIFA
∙ enasidenib (enasidenib mesylate) 100 mg;
∙ 2019-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02485435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97568
∙ IDHIFA
∙ enasidenib (enasidenib mesylate) 50 mg;
∙ 2019-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02485427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97567
∙ FUZEON
∙ enfuvirtide 108 mg / vial;
∙ 2003-08-18;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:18.08.04 – HIV FUSION INHIBITORS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02247725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72003
∙ LOVENOX WITH PRESERVATIVE 300MG/3ML
∙ enoxaparin sodium 100 mg / ml;
∙ 1998-01-21;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02236564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59932
∙ LOVENOX
∙ enoxaparin sodium 100 mg / ml;
∙ 2012-09-21;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02378442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86424
∙ NOROMBY
∙ enoxaparin sodium 100 mg / ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99586
∙ REDESCA
∙ enoxaparin sodium 100 mg / ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99843
∙ INCLUNOX
∙ enoxaparin sodium 100 mg / 1 ml;
∙ 2021-05-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99692
∙ LOVENOX HP
∙ enoxaparin sodium 120 mg / 0.8 ml;
∙ 2002-05-21;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02242692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66484
∙ NOROMBY HP
∙ enoxaparin sodium 120 mg / 0.8 ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99587
∙ INCLUNOX HP
∙ enoxaparin sodium 120 mg / 0.8 ml;
∙ 2021-05-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99693
∙ REDESCA HP
∙ enoxaparin sodium 120 mg / 0.8 ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99845
∙ LOVENOX HP
∙ enoxaparin sodium 150 mg / ml;
∙ 2012-12-07;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02378469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86426
∙ NOROMBY HP
∙ enoxaparin sodium 150 mg / ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99588
∙ REDESCA HP
∙ enoxaparin sodium 150 mg / ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99846
∙ INCLUNOX HP
∙ enoxaparin sodium 150 mg / 1 ml;
∙ 2021-05-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99694
∙ LOVENOX
∙ enoxaparin sodium 30 mg / 0.3 ml;
∙ 1993-12-31;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02012472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14049
∙ NOROMBY
∙ enoxaparin sodium 30 mg / 0.3 ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99582
∙ INCLUNOX
∙ enoxaparin sodium 30 mg / 0.3 ml;
∙ 2021-06-21;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99688
∙ REDESCA
∙ enoxaparin sodium 30 mg / 0.3 ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99839
∙ REDESCA
∙ enoxaparin sodium 300 mg / 3 ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99844
∙ LOVENOX
∙ enoxaparin sodium 40 mg / 0.4 ml;
∙ 1998-06-02;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02236883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60174
∙ NOROMBY
∙ enoxaparin sodium 40 mg / 0.4 ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99583
∙ INCLUNOX
∙ enoxaparin sodium 40 mg / 0.4 ml;
∙ 2021-05-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99689
∙ REDESCA
∙ enoxaparin sodium 40 mg / 0.4 ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99840
∙ LOVENOX
∙ enoxaparin sodium 60 mg / 0.6 ml;
∙ 2012-11-13;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02378426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86422
∙ NOROMBY
∙ enoxaparin sodium 60 mg / 0.6 ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99584
∙ INCLUNOX
∙ enoxaparin sodium 60 mg / 0.6 ml;
∙ 2021-05-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99690
∙ REDESCA
∙ enoxaparin sodium 60 mg / 0.6 ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99841
∙ LOVENOX
∙ enoxaparin sodium 80 mg / 0.8 ml;
∙ 2012-09-11;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02378434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86423
∙ NOROMBY
∙ enoxaparin sodium 80 mg / 0.8 ml;
∙ 2021-06-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02506483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99585
∙ INCLUNOX
∙ enoxaparin sodium 80 mg / 0.8 ml;
∙ 2021-05-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99691
∙ REDESCA
∙ enoxaparin sodium 80 mg / 0.8 ml;
∙ 2021-04-09;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.16 – HEPARINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.;
∙ DIN: 02509105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99842
∙ COVERGIRL TRUBLEND BASE BUSINESS SKIN PRIMER BASE POUR LA PEAU
∙ ensulizole 3 %;
∙ 2018-12-11;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ HFC PRESTIGE INTERNATIONAL CANADA INC;
∙ DIN: 02480131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97065
∙ COMTAN
∙ entacapone 200 mg;
∙ 2001-06-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67698
∙ TEVA-ENTACAPONE
∙ entacapone 200 mg;
∙ 2012-03-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02375559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86097
∙ SANDOZ ENTACAPONE
∙ entacapone 200 mg;
∙ 2012-03-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02380005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86585
∙ AURO-ENTECAVIR
∙ entecavir (entecavir monohydrate) 0.5 mg;
∙ 2015-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02448777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93451
∙ ENTECAVIR TABLETS
∙ entecavir (entecavir monohydrate) 0.5 mg;
∙ 2020-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ STRIDES PHARMA CANADA INC;
∙ DIN: 02453797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94033
∙ JAMP ENTECAVIR
∙ entecavir (entecavir monohydrate) 0.5 mg;
∙ 2018-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02467232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95562
∙ ACCEL-ENTECAVIR
∙ entecavir (entecavir monohydrate) 0.5 mg;
∙ 2020-03-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ ACCEL PHARMA INC;
∙ DIN: 02479907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97047
∙ MINT-ENTECAVIR
∙ entecavir (entecavir monohydrate) 0.5 mg;
∙ 2020-01-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02485907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97614
∙ BARACLUDE
∙ entecavir 0.5 mg;
∙ 2006-09-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02282224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76788
∙ APO-ENTECAVIR
∙ entecavir 0.5 mg;
∙ 2013-01-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02396955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88196
∙ PMS-ENTECAVIR
∙ entecavir 0.5 mg;
∙ 2014-09-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02430576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91502
∙ PMS-ENTECAVIR
∙ entecavir 1 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02430584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91503
∙ ROZLYTREK
∙ entrectinib 100 mg;
∙ 2020-03-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02495007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98496
∙ ROZLYTREK
∙ entrectinib 200 mg;
∙ 2020-03-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02495015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98497
∙ XTANDI
∙ enzalutamide 40 mg;
∙ 2013-06-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTELLAS PHARMA CANADA INC;
∙ DIN: 02407329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89203
∙ EPHEDRINE SULFATE INJECTION USP
∙ ephedrine sulfate 50 mg / ml;
∙ 1990-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00876534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11096
∙ EMERADE
∙ epinephrine (epinephrine bitartrate) 0.3 mg / 0.3 ml;
∙ 2020-10-08;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02458446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94557
∙ EMERADE
∙ epinephrine (epinephrine bitartrate) 0.5 mg / 0.5 ml;
∙ 2020-10-08;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02458454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94558
∙ ADRENALIN CHLORIDE SOL 1:1000 AMP
∙ epinephrine (epinephrine hydrochloride) 1 mg / ml;
∙ 1951-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ ERFA CANADA 2012 INC;
∙ DIN: 00155357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=940
∙ ADRENALIN CHLORIDE SOL 1:1000
∙ epinephrine (epinephrine hydrochloride) 1 mg / ml;
∙ 1951-12-31;
∙ Nasal | Nasale;
∙ Solution | Solution;
∙ 52:32.00 – VASOCONSTRICTORS;
∙ Ethical | Spécialité Médicale;
∙ ERFA CANADA 2012 INC;
∙ DIN: 00155365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1508
∙ ALLERJECT
∙ epinephrine 0.15 mg / 0.15 ml;
∙ 2012-12-11;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ KALEO INC;
∙ DIN: 02382059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86792
∙ EPIPEN JR
∙ epinephrine 0.15 mg / 0.3 ml;
∙ 1984-12-31;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ MYLAN SPECIALTY LP;
∙ DIN: 00578657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5970
∙ EPIPEN
∙ epinephrine 0.3 mg / 0.3 ml;
∙ 1980-12-31;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ MYLAN SPECIALTY LP;
∙ DIN: 00509558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3883
∙ ALLERJECT
∙ epinephrine 0.3 mg / 0.3 ml;
∙ 2012-12-11;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ KALEO INC;
∙ DIN: 02382067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86793
∙ EPINEPHRINE INJECTION USP
∙ epinephrine 1 mg / 1 ml;
∙ 1988-12-31;
∙ Intracardiac , Intramuscular , Intratracheal , Intravenous , Subcutaneous | Intracardiaque , Intramusculaire , Intratrachéale , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 00721891
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9164
∙ EPINEPHRINE INJECTION USP
∙ epinephrine 1 mg / 1 ml;
∙ 2015-07-20;
∙ Intramuscular , Intratracheal , Intravenous , Subcutaneous | Intramusculaire , Intratrachéale , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02435810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92016
∙ EPINEPHRINE INJECTION USP
∙ epinephrine 1 mg / 10 ml;
∙ 1987-12-31;
∙ Intracardiac , Intravenous | Intracardiaque , Intraveineuse;
∙ Solution | Solution;
∙ 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 00710814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8352
∙ EPIRUBICIN FOR INJECTION
∙ epirubicin hydrochloride 2 mg / ml;
∙ 2009-09-14;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02324091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80958
∙ INSPRA
∙ eplerenone 25 mg;
∙ 2009-05-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02323052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80855
∙ MINT-EPLERENONE
∙ eplerenone 25 mg;
∙ 2018-04-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02471442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96055
∙ INSPRA
∙ eplerenone 50 mg;
∙ 2009-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02323060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80856
∙ MINT-EPLERENONE
∙ eplerenone 50 mg;
∙ 2018-04-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02471450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96056
∙ EPREX STERILE SOLUTION 1000IU/0.5ML
∙ epoetin alfa 1000 unit / 0.5 ml;
∙ 1997-09-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02231583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50949
∙ EPREX STERILE SOLUTION 10000IU/1.0ML
∙ epoetin alfa 10000 unit / ml;
∙ 1997-09-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02231587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50953
∙ EPREX STERILE SOLUTION 2000IU/0.5ML
∙ epoetin alfa 2000 unit / 0.5 ml;
∙ 1997-09-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02231584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50950
∙ EPREX STERILE SOLUTION
∙ epoetin alfa 20000 unit / 0.5 ml;
∙ 2005-08-24;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02243239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67133
∙ EPREX STERILE SOLUTION 3000IU/0.3ML
∙ epoetin alfa 3000 unit / 0.3 ml;
∙ 1997-09-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02231585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50951
∙ EPREX STERILE SOLUTION
∙ epoetin alfa 30000 unit / 0.75 ml;
∙ 2007-11-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02288680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77409
∙ EPREX STERILE SOLUTION 4000IU/0.4ML
∙ epoetin alfa 4000 unit / 0.4 ml;
∙ 1997-09-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02231586
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50952
∙ EPREX STERILE SOLUTION 40000IU/ML
∙ epoetin alfa 40000 unit / ml;
∙ 1999-12-21;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02240722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64311
∙ EPREX STERILE SOLUTION 5000IU/0.5ML
∙ epoetin alfa 5000 unit / 0.5 ml;
∙ 2002-07-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02243400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67308
∙ EPREX STERILE SOLUTION 6000 IU/0.6 ML
∙ epoetin alfa 6000 unit / 0.6 ml;
∙ 2001-02-20;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02243401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67309
∙ EPREX STERILE SOLUTION 8000 IU/0.8 ML
∙ epoetin alfa 8000 unit / 0.8 ml;
∙ 2001-02-20;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02243403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67311
∙ FLOLAN
∙ epoprostenol (epoprostenol sodium) 0.5 mg / vial;
∙ 1997-07-28;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02230845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50121
∙ CARIPUL
∙ epoprostenol (epoprostenol sodium) 0.5 mg / vial;
∙ 2013-04-24;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02397447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88240
∙ FLOLAN
∙ epoprostenol (epoprostenol sodium) 1.5 mg / vial;
∙ 1997-07-28;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02230848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50122
∙ CARIPUL
∙ epoprostenol (epoprostenol sodium) 1.5 mg / vial;
∙ 2013-04-24;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02397455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88241
∙ TEVETEN
∙ eprosartan (eprosartan mesylate) 400 mg;
∙ 2000-09-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02240432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63981
∙ TEVETEN
∙ eprosartan (eprosartan mesylate) 600 mg;
∙ 2001-05-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02243942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67885
∙ NIASTASE RT
∙ eptacog alfa (activated) 1 mg / vial;
∙ 2015-05-05;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02417103
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90174
∙ NIASTASE RT
∙ eptacog alfa (activated) 2 mg / vial;
∙ 2015-05-05;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02417111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90175
∙ NIASTASE RT
∙ eptacog alfa (activated) 5 mg / vial;
∙ 2015-05-05;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02417138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90176
∙ INTEGRILIN
∙ eptifibatide 0.75 mg / ml;
∙ 1999-06-23;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02240351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63892
∙ INTEGRILIN
∙ eptifibatide 2 mg / ml;
∙ 1999-06-23;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02240352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63894
∙ BALVERSA
∙ erdafitinib 3 mg;
∙ 2019-12-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02493217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98320
∙ BALVERSA
∙ erdafitinib 4 mg;
∙ 2019-12-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02493225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98321
∙ BALVERSA
∙ erdafitinib 5 mg;
∙ 2019-12-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02493233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98322
∙ AIMOVIG
∙ erenumab 140 mg / ml;
∙ 2019-05-22;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02487306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97746
∙ AIMOVIG
∙ erenumab 70 mg / ml;
∙ 2018-12-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02479613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97029
∙ ERGONOVINE MALEATE INJECTION USP
∙ ergonovine maleate 0.25 mg / ml;
∙ 2016-02-19;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02441241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92564
∙ HALAVEN
∙ eribulin mesylate 0.5 mg / ml;
∙ 2012-03-19;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ EISAI LIMITED;
∙ DIN: 02377438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86314
∙ TARCEVA
∙ erlotinib (erlotinib hydrochloride) 100 mg;
∙ 2005-07-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02269015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75442
∙ TEVA-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 100 mg;
∙ 2014-12-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02377705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86352
∙ PMS-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 100 mg;
∙ 2016-07-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02454386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94096
∙ APO-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 100 mg;
∙ 2017-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02461870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94961
∙ NAT-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 100 mg;
∙ 2019-05-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02483920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97428
∙ TARCEVA
∙ erlotinib (erlotinib hydrochloride) 150 mg;
∙ 2005-07-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02269023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75443
∙ TEVA-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 150 mg;
∙ 2014-12-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02377713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86353
∙ PMS-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 150 mg;
∙ 2016-07-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02454394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94097
∙ APO-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 150 mg;
∙ 2017-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02461889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94962
∙ NAT-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 150 mg;
∙ 2019-05-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02483939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97429
∙ TARCEVA
∙ erlotinib (erlotinib hydrochloride) 25 mg;
∙ 2007-01-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02269007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75441
∙ TEVA-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 25 mg;
∙ 2014-12-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02377691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86351
∙ APO-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 25 mg;
∙ 2017-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02461862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94960
∙ NAT-ERLOTINIB
∙ erlotinib (erlotinib hydrochloride) 25 mg;
∙ 2019-05-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02483912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97427
∙ INVANZ
∙ ertapenem (ertapenem sodium) 1 g / vial;
∙ 2003-08-27;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02247437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71683
∙ ERTAPENEM FOR INJECTION
∙ ertapenem (ertapenem sodium) 1 g / vial;
∙ 2020-02-10;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02490773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98083
∙ ERTAPENEM FOR INJECTION
∙ ertapenem (ertapenem sodium) 1 g / vial;
∙ 2021-06-07;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02496127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98600
∙ ERTAPENEM FOR INJECTION
∙ ertapenem (ertapenem sodium) 1 g / vial;
∙ 2021-01-27;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.08 – CARBAPENEMS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02511150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100038
∙ ERYTHROCIN I.V.
∙ erythromycin (erythromycin lactobionate) 1 g / vial;
∙ 1988-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.12.04 – ERYTHROMYCINS;
∙ Prescription | Prescription;
∙ AMDIPHARM LIMITED;
∙ DIN: 00682276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9397
∙ ERYTHROCIN I.V.
∙ erythromycin (erythromycin lactobionate) 500 mg / vial;
∙ 1988-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.12.04 – ERYTHROMYCINS;
∙ Prescription | Prescription;
∙ AMDIPHARM LIMITED;
∙ DIN: 00682268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9396
∙ ERYTHRO-BASE
∙ erythromycin 250 mg;
∙ 1986-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.04 – ERYTHROMYCINS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00682020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6687
∙ ERYC DELAYED-RELEASE CAPSULES
∙ erythromycin 333 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule (Enteric-Coated) | Capsule (Entérosoluble);
∙ 08:12.12.04 – ERYTHROMYCINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00873454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10707
∙ PDP-ERYTHROMYCIN
∙ erythromycin 5 mg / g;
∙ 1991-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 01912755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11423
∙ ERYTHROMYCIN OPHTHALMIC OINTMENT USP
∙ erythromycin 5 mg / g;
∙ 2010-02-12;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ STERI-MED PHARMA INC.;
∙ DIN: 02326663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81202
∙ CHROM-O-RED DISCLOSING SOLUTION CONCENTRATE
∙ erythrosine 2 %;
∙ 1998-01-26;
∙ Dental | Dentaire;
∙ Solution | Solution;
∙ 34:00.00 – DENTAL AGENTS;
∙ Otc | En Vente Libre;
∙ GERMIPHENE CORPORATION;
∙ DIN: 02021137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26307
∙ CIPRALEX -10MG
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2005-02-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02263238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74862
∙ APO-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02295016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78034
∙ PMSC-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02303949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78926
∙ MYLAN-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02309467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79506
∙ TEVA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02318180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80368
∙ SANDOZ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02364077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84901
∙ RAN-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02385481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87111
∙ AURO-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02397358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88231
∙ MINT-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2015-03-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02407418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89210
∙ MAR-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02423480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90820
∙ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02424401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90910
∙ PRIVA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02426331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91093
∙ RIVA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02428830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91329
∙ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2015-01-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02429039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91347
∙ JAMP-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02429780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91422
∙ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2014-09-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02430118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91451
∙ ACH-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2016-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02434652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91896
∙ NAT-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02440296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92466
∙ PMS-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02469243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95793
∙ M-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2018-04-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96051
∙ NRA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2018-10-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96678
∙ AG-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2018-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96819
∙ BIO-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 10 mg;
∙ 2019-06-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02481154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97143
∙ KYE-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 15 mg;
∙ 2021-06-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ KYE PHARMACEUTICALS INC.;
∙ DIN: 02512653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100193
∙ CIPRALEX -20MG
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2005-02-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02263254
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74864
∙ APO-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02295024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78035
∙ MYLAN-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02309475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79507
∙ TEVA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02318202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80371
∙ SANDOZ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02364085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84902
∙ RAN-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02385503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87112
∙ AURO-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02397374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88233
∙ MINT-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2015-03-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02407434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89212
∙ MAR-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02423502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90822
∙ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02424428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90911
∙ PRIVA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02426358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91094
∙ RIVA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02428857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91332
∙ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2015-01-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02429047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91348
∙ JAMP-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02429799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91423
∙ ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2014-09-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02430126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91453
∙ ACH-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2016-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02434660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91897
∙ NAT-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02440318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92467
∙ PMS-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02469251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95794
∙ M-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2018-04-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96052
∙ NRA-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2018-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96679
∙ AG-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2018-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96821
∙ BIO-ESCITALOPRAM
∙ escitalopram (escitalopram oxalate) 20 mg;
∙ 2019-06-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02481170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97145
∙ ACT ESCITALOPRAM ODT
∙ escitalopram 10 mg;
∙ 2016-08-17;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02454297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94081
∙ ACT ESCITALOPRAM ODT
∙ escitalopram 20 mg;
∙ 2016-08-17;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02454300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94082
∙ SPRAVATO
∙ esketamine (esketamine hydrochloride) 28 mg / 2 act;
∙ 2020-06-11;
∙ Nasal | Nasale;
∙ Solution | Solution;
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Narcotic | Stupéfiant;
∙ JANSSEN INC;
∙ DIN: 02499290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98903
∙ APTIOM
∙ eslicarbazepine acetate 200 mg;
∙ 2014-08-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02426862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91141
∙ APTIOM
∙ eslicarbazepine acetate 400 mg;
∙ 2014-08-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02426870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91142
∙ APTIOM
∙ eslicarbazepine acetate 600 mg;
∙ 2014-08-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02426889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91143
∙ APTIOM
∙ eslicarbazepine acetate 800 mg;
∙ 2014-08-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02426897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91145
∙ BREVIBLOC INJECTION 10MG/ML
∙ esmolol hydrochloride 10 mg / ml;
∙ 1996-08-16;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02188880
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42910
∙ BREVIBLOC PREMIXED INJECTION
∙ esmolol hydrochloride 10 mg / ml;
∙ 2008-09-12;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02309238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79483
∙ TEVA-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium dihydrate) 20 mg;
∙ 2015-11-09;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02423855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90860
∙ SANDOZ ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium dihydrate) 20 mg;
∙ 2018-09-25;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02460920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94844
∙ TEVA-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium dihydrate) 40 mg;
∙ 2015-11-09;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02423863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90861
∙ ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium dihydrate) 40 mg;
∙ 2014-09-22;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02431173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91561
∙ SANDOZ ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium dihydrate) 40 mg;
∙ 2018-09-25;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02460939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94845
∙ NEXIUM
∙ esomeprazole (esomeprazole magnesium trihydrate) 10 mg / sachet;
∙ 2008-01-02;
∙ Oral | Orale;
∙ Granules For Suspension, Delayed Release | Granules Pour Suspension, À Libération Retardée;
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02300524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78581
∙ NEXIUM – 20MG
∙ esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
∙ 2001-08-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02244521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68498
∙ NEXIUM 24HR
∙ esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
∙ 2016-08-10;
∙ Oral | Orale;
∙ Capsule (Delayed Release) | Capsule (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02444712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92986
∙ MYL-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
∙ 2020-04-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02479419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97006
∙ NEXIUM – 40MG
∙ esomeprazole (esomeprazole magnesium trihydrate) 40 mg;
∙ 2001-08-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02244522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68499
∙ MYL-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium trihydrate) 40 mg;
∙ 2020-04-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02479427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97007
∙ APO-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium) 20 mg;
∙ 2012-03-02;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02339099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82472
∙ ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium) 20 mg;
∙ 2013-06-06;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02394839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87999
∙ RAN-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium) 20 mg;
∙ 2014-10-09;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02423979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90870
∙ APO-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium) 40 mg;
∙ 2011-03-07;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02339102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82473
∙ ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium) 40 mg;
∙ 2012-11-22;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02394847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88000
∙ RAN-ESOMEPRAZOLE
∙ esomeprazole (esomeprazole magnesium) 40 mg;
∙ 2014-10-09;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:28.36 – PROTON-PUMP INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02423987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90871
∙ ESTROGEL
∙ estradiol (estradiol hemihydrate) 0.06 % / w/w;
∙ 1998-11-16;
∙ Transdermal | Transdermique;
∙ Gel | Gel;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02238704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62136
∙ LUPIN-ESTRADIOL
∙ estradiol (estradiol hemihydrate) 0.5 mg;
∙ 2016-02-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ LUPIN PHARMA CANADA LIMITED;
∙ DIN: 02449048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93486
∙ LUPIN-ESTRADIOL
∙ estradiol (estradiol hemihydrate) 1 mg;
∙ 2016-02-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ LUPIN PHARMA CANADA LIMITED;
∙ DIN: 02449056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93487
∙ VAGIFEM 10
∙ estradiol (estradiol hemihydrate) 10 mcg;
∙ 2010-04-28;
∙ Vaginal | Vaginale;
∙ Vaginal Tablet | Comprimé Vaginal;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02325462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81084
∙ SANDOZ ESTRADIOL DERM 100
∙ estradiol (estradiol hemihydrate) 100 mcg / 24 hour;
∙ 2003-04-24;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02246969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71198
∙ LUPIN-ESTRADIOL
∙ estradiol (estradiol hemihydrate) 2 mg;
∙ 2016-02-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ LUPIN PHARMA CANADA LIMITED;
∙ DIN: 02449064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93488
∙ CLIMARA 25
∙ estradiol (estradiol hemihydrate) 25 mcg / 24 hour;
∙ 2004-03-12;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02247499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71749
∙ CLIMARA 50
∙ estradiol (estradiol hemihydrate) 50 mcg / 24 hour;
∙ 1997-12-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02231509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50849
∙ SANDOZ ESTRADIOL DERM 50
∙ estradiol (estradiol hemihydrate) 50 mcg / 24 hour;
∙ 2003-04-24;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02246967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71196
∙ SANDOZ ESTRADIOL DERM 75
∙ estradiol (estradiol hemihydrate) 75 mcg / 24 hour;
∙ 2003-04-24;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02246968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71197
∙ CLIMARA 75
∙ estradiol (estradiol hemihydrate) 75 mcg / 24 hour;
∙ 2004-03-12;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02247500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71750
∙ DIVIGEL
∙ estradiol 0.1 %;
∙ 2015-04-13;
∙ Transdermal | Transdermique;
∙ Gel | Gel;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02424835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90950
∙ DIVIGEL
∙ estradiol 0.1 %;
∙ 2015-04-13;
∙ Transdermal | Transdermique;
∙ Gel | Gel;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02424843
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90951
∙ DIVIGEL
∙ estradiol 0.1 %;
∙ 2015-04-13;
∙ Transdermal | Transdermique;
∙ Gel | Gel;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02424924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90959
∙ ESTRACE
∙ estradiol 0.5 mg;
∙ 1997-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ ACERUS PHARMACEUTICALS CORPORATION;
∙ DIN: 02225190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43420
∙ ESTRACE
∙ estradiol 1 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ ACERUS PHARMACEUTICALS CORPORATION;
∙ DIN: 02148587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19406
∙ ESTRADOT 100
∙ estradiol 100 mcg / 24 hour;
∙ 2001-09-05;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02244002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67945
∙ ESTRING
∙ estradiol 2 mg;
∙ 1995-12-31;
∙ Vaginal | Vaginale;
∙ Ring (Slow-Release) | Anneau (À Libération Lente);
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02168898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18640
∙ ESTRACE
∙ estradiol 2 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ ACERUS PHARMACEUTICALS CORPORATION;
∙ DIN: 02148595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19405
∙ OESCLIM
∙ estradiol 25 mcg / 24 hour;
∙ 2002-03-22;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02243722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67654
∙ ESTRADOT 25
∙ estradiol 25 mcg / 24 hour;
∙ 2002-10-03;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02245676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69776
∙ ESTRADOT 37.5
∙ estradiol 37.5 mcg / 24 hour;
∙ 2001-09-05;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02243999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67942
∙ OESCLIM
∙ estradiol 50 mcg / 24 hour;
∙ 2002-03-21;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02243724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67656
∙ ESTRADOT 50
∙ estradiol 50 mcg / 24 hour;
∙ 2001-09-05;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02244000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67943
∙ ESTRADOT 75
∙ estradiol 75 mcg / 24 hour;
∙ 2001-09-05;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02244001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67944
∙ ESTRAGYN VAGINAL CREAM
∙ estrone 0.1 % / w/w;
∙ 1987-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 68:16.04 – ESTROGENS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 00727369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7645
∙ LUNESTA
∙ eszopiclone 1 mg;
∙ 2020-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02453207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93974
∙ LUNESTA
∙ eszopiclone 2 mg;
∙ 2020-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02453215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93975
∙ LUNESTA
∙ eszopiclone 3 mg;
∙ 2020-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02453223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93976
∙ ERELZI
∙ etanercept 25 mg / 0.5 ml;
∙ 2017-12-08;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02462877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95074
∙ ENBREL
∙ etanercept 50 mg / ml;
∙ 2005-12-21;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ IMMUNEX CORPORATION;
∙ DIN: 02274728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76019
∙ BRENZYS
∙ etanercept 50 mg / ml;
∙ 2016-09-23;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SAMSUNG BIOEPIS CO., LTD;
∙ DIN: 02455323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94214
∙ BRENZYS
∙ etanercept 50 mg / ml;
∙ 2016-09-13;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SAMSUNG BIOEPIS CO., LTD;
∙ DIN: 02455331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94215
∙ ERELZI
∙ etanercept 50 mg / ml;
∙ 2017-08-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02462850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95072
∙ ERELZI
∙ etanercept 50 mg / ml;
∙ 2017-08-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02462869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95073
∙ VPI-ETHACRYNATE SODIUM
∙ ethacrynic acid (ethacrynate sodium) 50 mg / vial;
∙ 2018-05-22;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ VPI PHARMACEUTICALS INC;
∙ DIN: 02462362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95012
∙ ETHACRYNATE SODIUM FOR INJECTION USP
∙ ethacrynic acid (ethacrynate sodium) 50 mg / vial;
∙ 2018-03-29;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02469456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95825
∙ EDECRIN
∙ ethacrynic acid 25 mg;
∙ 2004-10-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02258528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74372
∙ ETIBI
∙ ethambutol hydrochloride 100 mg;
∙ 1972-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:16.04 – ANTITUBERCULOSIS AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00247960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1471
∙ ETIBI
∙ ethambutol hydrochloride 400 mg;
∙ 1972-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:16.04 – ANTITUBERCULOSIS AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00247979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1472
∙ PARSITAN 50MG
∙ ethopropazine (ethopropazine hydrochloride) 50 mg;
∙ 1952-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:08.04 – ANTIPARKINSONIAN AGENTS , 28:36.08 – ANTICHOLINERGIC AGENTS;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 01927744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12549
∙ ZARONTIN CAP 250MG
∙ ethosuximide 250 mg;
∙ 1960-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.20 – SUCCINIMIDES;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 00022799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=771
∙ ZARONTIN SYR 250MG/5ML
∙ ethosuximide 250 mg / 5 ml;
∙ 1964-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 28:12.20 – SUCCINIMIDES;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 00023485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=731
∙ ACT ETIDRONATE
∙ etidronate disodium 200 mg;
∙ 2004-11-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02248686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73050
∙ TOMVI
∙ etomidate 2 mg / ml;
∙ 2020-09-14;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02498650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98840
∙ NEXPLANON
∙ etonogestrel 68 mg;
∙ 2020-08-17;
∙ Subcutaneous | Sous-Cutanée;
∙ Implant | Implant;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02499509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98924
∙ ETOPOSIDE INJECTION
∙ etoposide 20 mg / ml;
∙ 1994-12-31;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02080036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16507
∙ VEPESID
∙ etoposide 50 mg;
∙ 1984-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 00616192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5963
∙ INTELENCE
∙ etravirine 100 mg;
∙ 2008-03-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02306778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79246
∙ INTELENCE
∙ etravirine 200 mg;
∙ 2011-12-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02375931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86137
∙ INTELENCE
∙ etravirine 25 mg;
∙ 2013-06-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02396750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88177
∙ AFINITOR
∙ everolimus 10 mg;
∙ 2010-01-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02339528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82512
∙ TEVA-EVEROLIMUS
∙ everolimus 10 mg;
∙ 2019-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02463253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95116
∙ SANDOZ EVEROLIMUS
∙ everolimus 10 mg;
∙ 2020-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02492946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98292
∙ AFINITOR DISPERZ
∙ everolimus 2 mg;
∙ 2014-11-28;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02425645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91028
∙ AFINITOR
∙ everolimus 2.5 mg;
∙ 2011-08-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02369257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85419
∙ TEVA-EVEROLIMUS
∙ everolimus 2.5 mg;
∙ 2019-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02463229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95113
∙ SANDOZ EVEROLIMUS
∙ everolimus 2.5 mg;
∙ 2020-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02492911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98290
∙ AFINITOR DISPERZ
∙ everolimus 3 mg;
∙ 2014-11-28;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02425653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91029
∙ AFINITOR
∙ everolimus 5 mg;
∙ 2010-03-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02339501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82511
∙ AFINITOR DISPERZ
∙ everolimus 5 mg;
∙ 2014-11-28;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02425661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91030
∙ TEVA-EVEROLIMUS
∙ everolimus 5 mg;
∙ 2019-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02463237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95114
∙ SANDOZ EVEROLIMUS
∙ everolimus 5 mg;
∙ 2020-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02492938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98291
∙ REPATHA
∙ evolocumab 120 mg / ml;
∙ 2017-04-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02459779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94710
∙ REPATHA
∙ evolocumab 140 mg / ml;
∙ 2015-09-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02446057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93132
∙ AROMASIN
∙ exemestane 25 mg;
∙ 2000-08-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02242705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66502
∙ ACT EXEMESTANE
∙ exemestane 25 mg;
∙ 2012-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02390183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87564
∙ MED-EXEMESTANE
∙ exemestane 25 mg;
∙ 2013-12-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ GENERIC MEDICAL PARTNERS INC;
∙ DIN: 02407841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89256
∙ TEVA-EXEMESTANE
∙ exemestane 25 mg;
∙ 2013-10-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02408473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89323
∙ BYETTA
∙ exenatide 10 mcg / act;
∙ 2011-05-31;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:20.06 – INCRETIN MIMETICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02361817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84686
∙ BYDUREON
∙ exenatide 2 mg / dose;
∙ 2016-02-16;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Suspension, Sustained-Release , Kit | Poudre Pour Suspension, À Libération Prolongée , Trousse;
∙ 68:20.06 – INCRETIN MIMETICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02448610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93433
∙ BYETTA
∙ exenatide 5 mcg / act;
∙ 2011-06-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:20.06 – INCRETIN MIMETICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02361809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84685
∙ EZETROL
∙ ezetimibe 10 mg;
∙ 2003-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02247521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71771
∙ TEVA-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02354101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83931
∙ PMS-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02416409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90096
∙ SANDOZ EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02416778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90134
∙ RAN-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02419548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90416
∙ EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02422549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90723
∙ MAR-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02422662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90733
∙ JAMP-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02423235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90797
∙ MINT-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02423243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90798
∙ BIO-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-10-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02425211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90986
∙ PRIVA-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02425238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90987
∙ ACH-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02425610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91025
∙ APO-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02427826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91232
∙ EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-09-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02429659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91410
∙ EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2014-10-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02431300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91572
∙ GLN-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2019-07-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02460750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94824
∙ M-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2017-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02467437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95581
∙ AURO-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2018-04-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02469286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95800
∙ AG-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2018-07-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02475898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96664
∙ EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2018-08-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02478544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96932
∙ NRA-EZETIMIBE
∙ ezetimibe 10 mg;
∙ 2018-12-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02481669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97215
∙ CORIFACT 1250
∙ factor xiii 1250 unit / vial;
∙ 2014-04-03;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02418746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90330
∙ CORIFACT 250
∙ factor xiii 250 unit / vial;
∙ 2014-04-03;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02418738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90329
∙ FAMVIR
∙ famciclovir 125 mg;
∙ 1996-09-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ ATNAHS PHARMA UK LIMITED;
∙ DIN: 02229110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43513
∙ SANDOZ FAMCICLOVIR
∙ famciclovir 125 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02278634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76420
∙ APO-FAMCICLOVIR
∙ famciclovir 125 mg;
∙ 2007-02-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02292025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77739
∙ ACT FAMCICLOVIR
∙ famciclovir 125 mg;
∙ 2008-10-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02305682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79124
∙ FAMVIR
∙ famciclovir 250 mg;
∙ 1996-09-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ ATNAHS PHARMA UK LIMITED;
∙ DIN: 02229129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43514
∙ PMS-FAMCICLOVIR
∙ famciclovir 250 mg;
∙ 2006-11-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02278103
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76368
∙ SANDOZ FAMCICLOVIR
∙ famciclovir 250 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02278642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76421
∙ APO-FAMCICLOVIR
∙ famciclovir 250 mg;
∙ 2007-02-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02292041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77741
∙ ACT FAMCICLOVIR
∙ famciclovir 250 mg;
∙ 2008-10-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02305690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79125
∙ FAMVIR
∙ famciclovir 500 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ ATNAHS PHARMA UK LIMITED;
∙ DIN: 02177102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18768
∙ SANDOZ FAMCICLOVIR
∙ famciclovir 500 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02278650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76422
∙ APO-FAMCICLOVIR
∙ famciclovir 500 mg;
∙ 2007-02-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02292068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77742
∙ ACT FAMCICLOVIR
∙ famciclovir 500 mg;
∙ 2008-10-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02305704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79126
∙ PEPCID AC
∙ famotidine 10 mg;
∙ 1996-07-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02185938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42879
∙ FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
∙ famotidine 10 mg / ml;
∙ 2003-10-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72016
∙ FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL)
∙ famotidine 10 mg / ml;
∙ 2003-10-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72026
∙ TEVA-FAMOTIDINE
∙ famotidine 20 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02022133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13654
∙ MAXIMUM STRENGTH PEPCID AC
∙ famotidine 20 mg;
∙ 2007-04-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02273357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75884
∙ FAMOTIDINE TABLETS
∙ famotidine 20 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83631
∙ TEVA-FAMOTIDINE
∙ famotidine 40 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02022141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13655
∙ FAMOTIDINE TABLETS
∙ famotidine 40 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83632
∙ FAMPYRA
∙ fampridine 10 mg;
∙ 2012-02-24;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ BIOGEN CANADA INC;
∙ DIN: 02379910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86577
∙ TARO-FAMPRIDINE
∙ fampridine 10 mg;
∙ 2020-11-24;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02482398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97285
∙ PMS-FAMPRIDINE
∙ fampridine 10 mg;
∙ 2021-04-12;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02496216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98608
∙ TEVA-FEBUXOSTAT
∙ febuxostat (febuxostat hemihydrate) 80 mg;
∙ 2019-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02466198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95449
∙ MAR-FEBUXOSTAT
∙ febuxostat (febuxostat hemihydrate) 80 mg;
∙ 2019-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02473607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96300
∙ ULORIC
∙ febuxostat 80 mg;
∙ 2010-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02357380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84250
∙ JAMP FEBUXOSTAT
∙ febuxostat 80 mg;
∙ 2020-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02490870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98091
∙ INREBIC
∙ fedratinib (fedratinib hydrochloride) 100 mg;
∙ 2021-05-20;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02502445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99202
∙ PLENDIL 10 MG
∙ felodipine 10 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 00851787
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12459
∙ SANDOZ FELODIPINE
∙ felodipine 10 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02280272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76594
∙ APO-FELODIPINE
∙ felodipine 10 mg;
∙ 2016-04-22;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93877
∙ PLENDIL 2.5 MG
∙ felodipine 2.5 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02057778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15574
∙ APO-FELODIPINE
∙ felodipine 2.5 mg;
∙ 2016-04-22;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93875
∙ PLENDIL 5 MG
∙ felodipine 5 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 00851779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12458
∙ SANDOZ FELODIPINE
∙ felodipine 5 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02280264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76593
∙ APO-FELODIPINE
∙ felodipine 5 mg;
∙ 2016-04-22;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93876
∙ APO-FENO-SUPER
∙ fenofibrate 100 mg;
∙ 2006-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02246859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71082
∙ LIPIDIL EZ
∙ fenofibrate 145 mg;
∙ 2005-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02269082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75448
∙ TARO-FENOFIBRATE E
∙ fenofibrate 145 mg;
∙ 2020-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02454696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94139
∙ SANDOZ FENOFIBRATE E
∙ fenofibrate 145.0 mg;
∙ 2012-08-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02390701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87611
∙ LIPIDIL SUPRA
∙ fenofibrate 160 mg;
∙ 2000-03-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02241602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65259
∙ APO-FENO-SUPER
∙ fenofibrate 160 mg;
∙ 2006-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02246860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71083
∙ AA-FENO-MICRO
∙ fenofibrate 200 mg;
∙ 1999-03-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02239864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63352
∙ LIPIDIL EZ
∙ fenofibrate 48 mg;
∙ 2005-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02269074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75447
∙ SANDOZ FENOFIBRATE E
∙ fenofibrate 48.0 mg;
∙ 2012-12-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02390698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87610
∙ AA-FENO-MICRO
∙ fenofibrate 67 mg;
∙ 2001-02-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02243180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67060
∙ FENTORA
∙ fentanyl (fentanyl citrate) 100 mcg;
∙ 2014-05-14;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02408007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89270
∙ FENTANYL INJECTION BP
∙ fentanyl (fentanyl citrate) 100 mcg / 2 ml;
∙ 2020-09-09;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ STERIMAX INC;
∙ DIN: 02496143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98602
∙ FENTANYL INJECTION BP
∙ fentanyl (fentanyl citrate) 1000 mcg / 20 ml;
∙ 2020-04-23;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ STERIMAX INC;
∙ DIN: 02496178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98604
∙ FENTORA
∙ fentanyl (fentanyl citrate) 200 mcg;
∙ 2014-05-14;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02408015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89271
∙ FENTANYL INJECTION BP
∙ fentanyl (fentanyl citrate) 250 mcg / 5 ml;
∙ 2020-04-23;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ STERIMAX INC;
∙ DIN: 02496151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98603
∙ FENTANYL INJECTION BP
∙ fentanyl (fentanyl citrate) 2500 mcg / 50 ml;
∙ 2020-04-23;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ STERIMAX INC;
∙ DIN: 02496186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98605
∙ FENTORA
∙ fentanyl (fentanyl citrate) 400 mcg;
∙ 2014-05-14;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02408023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89272
∙ FENTANYL CITRATE INJECTION USP
∙ fentanyl (fentanyl citrate) 50 mcg / ml;
∙ 2000-02-10;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Liquid | Liquide;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02240434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63983
∙ FENTANYL CITRATE INJECTION SDZ
∙ fentanyl (fentanyl citrate) 50 mcg / ml;
∙ 2013-02-21;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02384124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86987
∙ FENTANYL CITRATE INJECTION USP
∙ fentanyl (fentanyl citrate) 50 mcg / ml;
∙ 2016-04-18;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TELIGENT OU;
∙ DIN: 02385406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87103
∙ FENTANYL CITRATE INJECTION, USP
∙ fentanyl (fentanyl citrate) 50 mcg / ml;
∙ 2021-06-18;
∙ Intramuscular , Intravenous , Epidural | Intramusculaire , Intraveineuse , Épidurale;
∙ Solution | Solution;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02501554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99116
∙ FENTORA
∙ fentanyl (fentanyl citrate) 600 mcg;
∙ 2014-05-14;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02408031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89273
∙ FENTORA
∙ fentanyl (fentanyl citrate) 800 mcg;
∙ 2014-05-14;
∙ Buccal , Sublingual | Buccale , Sublinguale;
∙ Tablet (Effervescent) | Comprimé (Effervescent);
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02408058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89274
∙ TEVA-FENTANYL
∙ fentanyl 100 mcg / hour;
∙ 2006-07-04;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02282984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76860
∙ SANDOZ FENTANYL PATCH
∙ fentanyl 100 mcg / hour;
∙ 2010-11-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81248
∙ PMS-FENTANYL MTX
∙ fentanyl 100 mcg / hour;
∙ 2010-03-18;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02341417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82693
∙ TEVA-FENTANYL
∙ fentanyl 12 mcg / hour;
∙ 2008-06-27;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02311925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79746
∙ SANDOZ FENTANYL PATCH
∙ fentanyl 12 mcg / hour;
∙ 2010-11-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81243
∙ PMS-FENTANYL MTX
∙ fentanyl 12 mcg / hour;
∙ 2010-03-18;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02341379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82689
∙ TEVA-FENTANYL
∙ fentanyl 25 mcg / hour;
∙ 2006-07-04;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02282941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76857
∙ SANDOZ FENTANYL PATCH
∙ fentanyl 25 mcg / hour;
∙ 2010-11-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81244
∙ PMS-FENTANYL MTX
∙ fentanyl 25 mcg / hour;
∙ 2010-03-18;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02341387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82690
∙ SANDOZ FENTANYL PATCH
∙ fentanyl 37 mcg / hour;
∙ 2010-11-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81245
∙ TEVA-FENTANYL
∙ fentanyl 50 mcg / hour;
∙ 2006-07-04;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02282968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76858
∙ SANDOZ FENTANYL PATCH
∙ fentanyl 50 mcg / hour;
∙ 2010-11-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81246
∙ PMS-FENTANYL MTX
∙ fentanyl 50 mcg / hour;
∙ 2010-03-18;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02341395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82691
∙ TEVA-FENTANYL
∙ fentanyl 75 mcg / hour;
∙ 2006-07-04;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ TEVA CANADA LIMITED;
∙ DIN: 02282976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76859
∙ SANDOZ FENTANYL PATCH
∙ fentanyl 75 mcg / hour;
∙ 2010-11-01;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02327155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81247
∙ PMS-FENTANYL MTX
∙ fentanyl 75 mcg / hour;
∙ 2010-03-18;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PHARMASCIENCE INC;
∙ DIN: 02341409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82692
∙ TOVIAZ
∙ fesoterodine fumarate 4 mg;
∙ 2012-04-19;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 86:12.04 – Antimuscarinics;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02380021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86587
∙ TOVIAZ
∙ fesoterodine fumarate 8 mg;
∙ 2012-04-19;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 86:12.04 – Antimuscarinics;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02380048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86588
∙ ALLEGRA 24 HOUR
∙ fexofenadine hydrochloride 120 mg;
∙ 2001-01-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 02242819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66647
∙ ALLEGRA 12 HOUR
∙ fexofenadine hydrochloride 60 mg;
∙ 1997-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 02231462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50779
∙ FIBRYGA
∙ fibrinogen (human) 1 g / vial;
∙ 2018-08-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02464616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95274
∙ RIASTAP
∙ fibrinogen (human) 1000 mg / vial;
∙ 2013-01-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02393352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87858
∙ DIFICID
∙ fidaxomicin 200 mg;
∙ 2012-06-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02387174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87275
∙ NEUPOGEN
∙ filgrastim 300 mcg / ml;
∙ 1992-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 01968017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12474
∙ NIVESTYM
∙ filgrastim 300 mcg / ml;
∙ 2020-06-10;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02485591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97583
∙ GRASTOFIL
∙ filgrastim 300 mcg / 0.5 ml;
∙ 2016-03-17;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ APOTEX INC;
∙ DIN: 02441489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92587
∙ NIVESTYM
∙ filgrastim 300 mcg / 0.5 ml;
∙ 2020-05-11;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02485575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97581
∙ GRASTOFIL
∙ filgrastim 480 mcg / 0.8 ml;
∙ 2016-11-28;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ APOTEX INC;
∙ DIN: 02454548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94117
∙ NIVESTYM
∙ filgrastim 480 mcg / 0.8 ml;
∙ 2020-05-11;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02485583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97582
∙ NIVESTYM
∙ filgrastim 480 mcg / 1.6 ml;
∙ 2020-06-10;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02485656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97588
∙ NEUPOGEN
∙ filgrastim 600 mcg / ml;
∙ 2016-01-28;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02420104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90471
∙ NEUPOGEN
∙ filgrastim 600 mcg / ml;
∙ 2016-02-02;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:16.00 – HEMATOPOIETIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02420112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90472
∙ PROPECIA
∙ finasteride 1 mg;
∙ 1998-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02238213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61606
∙ PMS-FINASTERIDE
∙ finasteride 1 mg;
∙ 2010-05-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02320169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80561
∙ SANDOZ FINASTERIDE A
∙ finasteride 1 mg;
∙ 2010-05-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02339471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82509
∙ AURO-FINASTERIDE 1MG
∙ finasteride 1 mg;
∙ 2014-11-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02428148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91262
∙ FINASTERIDE
∙ finasteride 1 mg;
∙ 2015-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02445085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93029
∙ FINASTERIDE
∙ finasteride 1 mg;
∙ 2015-11-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02447568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93314
∙ PROSCAR
∙ finasteride 5 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02010909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13370
∙ PMS-FINASTERIDE
∙ finasteride 5 mg;
∙ 2010-03-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02310112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79578
∙ SANDOZ FINASTERIDE
∙ finasteride 5 mg;
∙ 2010-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02322579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80802
∙ TEVA-FINASTERIDE
∙ finasteride 5 mg;
∙ 2010-04-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02348500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83386
∙ FINASTERIDE
∙ finasteride 5 mg;
∙ 2010-04-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02350270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83549
∙ ACH-FINASTERIDE
∙ finasteride 5 mg;
∙ 2010-10-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02355043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84031
∙ JAMP-FINASTERIDE
∙ finasteride 5 mg;
∙ 2010-10-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02357224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84235
∙ APO-FINASTERIDE
∙ finasteride 5 mg;
∙ 2011-11-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02365383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85029
∙ AG-FINASTERIDE
∙ finasteride 5 mg;
∙ 2020-01-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02374404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85961
∙ MINT-FINASTERIDE
∙ finasteride 5 mg;
∙ 2012-07-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02389878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87534
∙ AURO-FINASTERIDE
∙ finasteride 5 mg;
∙ 2013-05-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02405814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89058
∙ FINASTERIDE
∙ finasteride 5 mg;
∙ 2015-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02445077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93028
∙ FINASTERIDE
∙ finasteride 5 mg;
∙ 2015-11-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02447541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93313
∙ RIVA-FINASTERIDE
∙ finasteride 5 mg;
∙ 2016-06-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02455013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94182
∙ GILENYA
∙ fingolimod (fingolimod hydrochloride) 0.25 mg;
∙ 2019-01-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02482533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97297
∙ GILENYA
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2011-03-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02365480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85038
∙ TEVA-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-11-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02469561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95837
∙ TARO-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-10-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02469618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95841
∙ MYLAN-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-09-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02469715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95854
∙ PMS-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-08-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02469782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95865
∙ APO-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-11-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02469936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95885
∙ MAR-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-10-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02474743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96493
∙ ACH-FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-12-11;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02475669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96603
∙ SANDOZ FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-10-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02482606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97303
∙ JAMP FINGOLIMOD
∙ fingolimod (fingolimod hydrochloride) 0.5 mg;
∙ 2019-10-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02487772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97793
∙ APO-FLECAINIDE
∙ flecainide acetate 100 mg;
∙ 2006-05-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02275546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76118
∙ AURO-FLECAINIDE
∙ flecainide acetate 100 mg;
∙ 2017-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02459965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94727
∙ MAR-FLECAINIDE
∙ flecainide acetate 100 mg;
∙ 2021-01-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02476185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96720
∙ JAMP FLECAINIDE
∙ flecainide acetate 100 mg;
∙ 2020-11-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02493713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98371
∙ APO-FLECAINIDE
∙ flecainide acetate 50 mg;
∙ 2006-05-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02275538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76117
∙ AURO-FLECAINIDE
∙ flecainide acetate 50 mg;
∙ 2017-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02459957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94726
∙ MAR-FLECAINIDE
∙ flecainide acetate 50 mg;
∙ 2021-01-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02476177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96719
∙ JAMP FLECAINIDE
∙ flecainide acetate 50 mg;
∙ 2020-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.12 – CLASS IC ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02493705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98370
∙ ADDYI
∙ flibanserin 100 mg;
∙ 2018-11-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02473550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96294
∙ TEVA-FLUCONAZOLE
∙ fluconazole 100 mg;
∙ 2002-07-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02236979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60274
∙ APO-FLUCONAZOLE
∙ fluconazole 100 mg;
∙ 1998-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02237371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60694
∙ MYLAN-FLUCONAZOLE
∙ fluconazole 100 mg;
∙ 2002-06-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02245293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69317
∙ PMS-FLUCONAZOLE
∙ fluconazole 100 mg;
∙ 2002-06-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02245644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69744
∙ ACT FLUCONAZOLE
∙ fluconazole 100 mg;
∙ 2007-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02281279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76692
∙ PRO-FLUCONAZOLE
∙ fluconazole 100 mg;
∙ 2008-07-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79630
∙ DIFLUCAN ONE
∙ fluconazole 150 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ PFIZER CANADA ULC;
∙ DIN: 02141442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17789
∙ APO-FLUCONAZOLE-150
∙ fluconazole 150 mg;
∙ 2000-03-20;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02241895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65565
∙ RIVA-FLUCONAZOLE
∙ fluconazole 150 mg;
∙ 2004-07-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02255510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74071
∙ CANESORAL
∙ fluconazole 150 mg;
∙ 2010-03-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02311690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79724
∙ FLUCONAZOLE 150
∙ fluconazole 150 mg;
∙ 2011-03-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02352133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83738
∙ MAR-FLUCONAZOLE-150
∙ fluconazole 150 mg;
∙ 2016-12-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02428792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91325
∙ JAMP-FLUCONAZOLE
∙ fluconazole 150 mg;
∙ 2015-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02432471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91671
∙ PRIVA-FLUCONAZOLE
∙ fluconazole 150 mg;
∙ 2015-05-12;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ PHARMAPAR INC;
∙ DIN: 02433702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91806
∙ BIO-FLUCONAZOLE
∙ fluconazole 150 mg;
∙ 2019-09-20;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:14.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BIOMED PHARMA;
∙ DIN: 02462168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94989
∙ DIFLUCAN
∙ fluconazole 2 mg / ml;
∙ 1990-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00891835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10954
∙ FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP
∙ fluconazole 2 mg / ml;
∙ 2005-09-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02261472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74685
∙ FLUCONAZOLE INJECTION SDZ
∙ fluconazole 2 mg / ml;
∙ 2012-10-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02388448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87397
∙ TEVA-FLUCONAZOLE
∙ fluconazole 50 mg;
∙ 2002-07-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02236978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60273
∙ APO-FLUCONAZOLE
∙ fluconazole 50 mg;
∙ 1998-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02237370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60693
∙ MYLAN-FLUCONAZOLE
∙ fluconazole 50 mg;
∙ 2002-06-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02245292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69316
∙ PMS-FLUCONAZOLE
∙ fluconazole 50 mg;
∙ 2002-06-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02245643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69743
∙ ACT FLUCONAZOLE
∙ fluconazole 50 mg;
∙ 2007-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02281260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76691
∙ DIFLUCAN
∙ fluconazole 50 mg / 5 ml;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.08 – AZOLES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02024152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18010
∙ FLUDARA
∙ fludarabine phosphate 10 mg;
∙ 2002-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02246226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70384
∙ FLUDARABINE PHOSPHATE FOR INJECTION
∙ fludarabine phosphate 25 mg / ml;
∙ 2006-12-04;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02283859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76943
∙ FLORINEF
∙ fludrocortisone 21-acetate 0.1 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02086026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19460
∙ FLUMAZENIL INJECTION
∙ flumazenil 0.1 mg / ml;
∙ 2004-04-21;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02249561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73439
∙ FLUMAZENIL INJECTION
∙ flumazenil 0.1 mg / ml;
∙ 2007-11-05;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02266342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75176
∙ FLUNARIZINE
∙ flunarizine (flunarizine hydrochloride) 5 mg;
∙ 2002-08-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:04.16 – PIPERAZINE DERIVATIVES , 28:32.92 – ANTIMIGRAINE AGENTS, MISCELLANEOUS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02246082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70217
∙ DERMA SMOOTHE/FS LIQ 0.01%
∙ fluocinolone acetonide 0.01 %;
∙ 1991-12-31;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ HILL DERMACEUTICALS INC;
∙ DIN: 00873292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13875
∙ DERMOTIC OIL EAR DROPS
∙ fluocinolone acetonide 0.01 % / w/v;
∙ 2008-01-09;
∙ Otic | Otique;
∙ Solution | Solution;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ HILL DERMACEUTICALS INC;
∙ DIN: 02300559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78584
∙ SYNALAR
∙ fluocinolone acetonide 0.025 %;
∙ 1996-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02162512
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20258
∙ TIAMOL CREAM 0.05%
∙ fluocinonide 0.05 %;
∙ 1983-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 00598933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5439
∙ LYDERM CREAM 0.05%
∙ fluocinonide 0.05 %;
∙ 1988-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 00716863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9276
∙ LYDERM OINTMENT 0.05%
∙ fluocinonide 0.05 %;
∙ 1999-10-15;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 02236996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60294
∙ LYDERM GEL 0.05%
∙ fluocinonide 0.05 %;
∙ 1998-04-27;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 02236997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60295
∙ LIDEX
∙ fluocinonide 0.05 % / w/w;
∙ 1995-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02161966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19203
∙ LIDEMOL
∙ fluocinonide 0.05 % / w/w;
∙ 1995-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02163152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19312
∙ LIDEX
∙ fluocinonide 0.05 % / w/w;
∙ 1995-12-31;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02161974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19317
∙ LIDEX
∙ fluocinonide 0.05 % / w/w;
∙ 1996-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02161923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20008
∙ FLUORESCITE
∙ fluorescein (fluorescein sodium) 10 % / w/v;
∙ 1980-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ALCON CANADA INC;
∙ DIN: 00505005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3781
∙ DIOFLUOR STRIPS
∙ fluorescein sodium 1 mg;
∙ 1995-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Strip | Bandelette;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ DIOPTIC PHARMACEUTICALS INC;
∙ DIN: 02160773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19197
∙ MINIMS FLUORESCEIN SODIUM
∙ fluorescein sodium 2 % / w/v;
∙ 1995-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 36:58.00 – OCULAR DISORDERS;
∙ Ethical | Spécialité Médicale;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02148390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18747
∙ FML 0.1%
∙ fluorometholone 0.1 %;
∙ 1972-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 00247855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1470
∙ SANDOZ FLUOROMETHOLONE
∙ fluorometholone 0.1 %;
∙ 2012-07-24;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00432814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42778
∙ FLAREX
∙ fluorometholone acetate 0.1 % / w/v;
∙ 1987-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00756784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8229
∙ TOLAK
∙ fluorouracil (fluorouracil sodium) 4 % / w/w;
∙ 2019-06-25;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ HILL DERMACEUTICALS INC;
∙ DIN: 02485346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97559
∙ EFUDEX
∙ fluorouracil 5 % / w/w;
∙ 1975-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00330582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2138
∙ FLUOROURACIL INJECTION
∙ fluorouracil 5 g / 100 ml;
∙ 2019-06-06;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BIOLYSE PHARMA CORPORATION;
∙ DIN: 02473771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96320
∙ FLUOROURACIL INJECTION
∙ fluorouracil 50 mg / ml;
∙ 1989-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00012882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10015
∙ FLUOROURACIL INJECTION USP
∙ fluorouracil 50 mg / ml;
∙ 2014-10-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02413450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89810
∙ PROZAC CAPSULES 10MG
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02018985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13723
∙ PMS-FLUOXETINE – CAP 10MG
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02177579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19074
∙ TEVA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02216582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19916
∙ APO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02216353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19962
∙ FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2009-10-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02286068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77154
∙ RIVA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2010-10-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02305461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79103
∙ PRO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2008-10-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02314991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80053
∙ FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2011-10-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02374447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85969
∙ MINT-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2012-03-20;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02380560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86635
∙ AURO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2012-07-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02385627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87125
∙ ACH-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2012-10-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02393441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87867
∙ JAMP-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2013-04-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02401894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88677
∙ PRIVA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2018-12-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02448416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93410
∙ BIO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2016-10-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02448424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93411
∙ AG-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2019-03-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02485052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97531
∙ NRA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 10 mg;
∙ 2020-11-23;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02503875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99331
∙ PROZAC CAPSULES 20MG
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 00636622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9703
∙ PMS-FLUOXETINE – CAP 20MG
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02177587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19064
∙ TEVA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02216590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19895
∙ APO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02216361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19961
∙ FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2009-10-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02286076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77155
∙ RIVA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2009-09-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02305488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79104
∙ PRO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2008-10-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02315009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80054
∙ FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2011-10-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02374455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85980
∙ MINT-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2012-03-20;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02380579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86636
∙ ACH-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2012-05-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02383241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86901
∙ AURO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2012-07-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02385635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87126
∙ JAMP-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2012-06-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02386402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87199
∙ PRIVA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2018-05-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02448408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93409
∙ BIO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2016-10-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02448432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93412
∙ AG-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2019-03-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02485060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97532
∙ NRA-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg;
∙ 2020-11-23;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02503883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99332
∙ APO-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg / 5 ml;
∙ 1997-06-16;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02231328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50635
∙ ODAN-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 20 mg / 5 ml;
∙ 2017-01-24;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02459361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94657
∙ PMS-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 40 mg;
∙ 2018-02-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02464640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95277
∙ PMS-FLUOXETINE
∙ fluoxetine (fluoxetine hydrochloride) 60 mg;
∙ 2018-08-01;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02464659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95278
∙ FLUANXOL 0.5MG – TAB
∙ flupentixol (flupentixol dihydrochloride) 0.5 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.32 – THIOXANTHENES;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02156008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18739
∙ FLUANXOL 3MG – TAB
∙ flupentixol (flupentixol dihydrochloride) 3 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.32 – THIOXANTHENES;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02156016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18740
∙ FLUANXOL DEPOT 10%- LIQ IM 100MG/ML
∙ flupentixol decanoate 100 mg / ml;
∙ 1995-12-31;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 28:16.08.32 – THIOXANTHENES;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02156040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18737
∙ FLUANXOL DEPOT 2% -LIQ IM 20MG/ML
∙ flupentixol decanoate 20 mg / ml;
∙ 1995-12-31;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 28:16.08.32 – THIOXANTHENES;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02156032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18800
∙ FLUPHENAZINE
∙ fluphenazine hydrochloride 1 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.24 – PHENOTHIAZINES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00405345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2858
∙ FLUPHENAZINE
∙ fluphenazine hydrochloride 2 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.24 – PHENOTHIAZINES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00410632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2861
∙ FLUPHENAZINE
∙ fluphenazine hydrochloride 5 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.24 – PHENOTHIAZINES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00405361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2860
∙ FLURAZEPAM
∙ flurazepam hydrochloride 15 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00521698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4728
∙ FLURAZEPAM
∙ flurazepam hydrochloride 30 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00521701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4729
∙ FLURBIPROFEN
∙ flurbiprofen 100 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 01912038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11465
∙ FLURBIPROFEN
∙ flurbiprofen 50 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 01912046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11466
∙ FLUTAMIDE
∙ flutamide 250 mg;
∙ 1998-10-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02238560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61987
∙ ARNUITY ELLIPTA
∙ fluticasone furoate 100 mcg / act;
∙ 2016-01-26;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Powder | Poudre;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02446561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93200
∙ ARNUITY ELLIPTA
∙ fluticasone furoate 200 mcg / act;
∙ 2015-12-14;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Powder | Poudre;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02446588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93201
∙ AVAMYS
∙ fluticasone furoate 27.5 mcg / act;
∙ 2007-10-22;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02298589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78388
∙ FLOVENT DISKUS
∙ fluticasone propionate 100 mcg / act;
∙ 1998-04-02;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02237245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60565
∙ AERMONY RESPICLICK
∙ fluticasone propionate 113 mcg / act;
∙ 2020-09-30;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02467909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95625
∙ FLOVENT HFA
∙ fluticasone propionate 125 mcg / act;
∙ 2001-12-20;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02244292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68259
∙ AERMONY RESPICLICK
∙ fluticasone propionate 232 mcg / act;
∙ 2020-09-30;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02467917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95626
∙ FLOVENT DISKUS
∙ fluticasone propionate 250 mcg / act;
∙ 1998-04-02;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02237246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60566
∙ FLOVENT HFA
∙ fluticasone propionate 250 mcg / act;
∙ 2001-12-20;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02244293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68260
∙ PMS-FLUTICASONE HFA
∙ fluticasone propionate 250 mcg / act;
∙ 2021-01-21;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02503131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99264
∙ APO-FLUTICASONE HFA
∙ fluticasone propionate 250 mcg / act;
∙ 2021-04-26;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02510987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100023
∙ FLOVENT HFA
∙ fluticasone propionate 50 mcg / act;
∙ 2001-12-20;
∙ Inhalation , Oral | Inhalation , Orale;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02244291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68258
∙ FLONASE ALLERGY RELIEF
∙ fluticasone propionate 50 mcg / act;
∙ 2017-02-01;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.00 – ANTI-INFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02248307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72648
∙ APO-FLUTICASONE
∙ fluticasone propionate 50 mcg / act;
∙ 2007-07-05;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02294745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78009
∙ TEVA-FLUTICASONE
∙ fluticasone propionate 50 mcg / act;
∙ 2017-09-28;
∙ Nasal | Nasale;
∙ Metered-Dose Pump | Pompe À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02453738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94027
∙ 24HR NASAL ALLERGY RELIEF
∙ fluticasone propionate 50 mcg / act;
∙ 2017-07-19;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02460513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94795
∙ FLOVENT DISKUS
∙ fluticasone propionate 500 mcg / act;
∙ 1998-04-02;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02237247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60567
∙ AERMONY RESPICLICK
∙ fluticasone propionate 55 mcg / act;
∙ 2020-09-30;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02467895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95621
∙ TEVA-FLUVASTATIN
∙ fluvastatin (fluvastatin sodium) 20 mg;
∙ 2012-12-11;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02299224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78461
∙ TEVA-FLUVASTATIN
∙ fluvastatin (fluvastatin sodium) 40 mg;
∙ 2012-12-11;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02299232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78462
∙ LUVOX
∙ fluvoxamine maleate 100 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 01919369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11751
∙ APO-FLUVOXAMINE TABLETS
∙ fluvoxamine maleate 100 mg;
∙ 1998-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02231330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50638
∙ FLUVOXAMINE-100
∙ fluvoxamine maleate 100 mg;
∙ 1998-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02236754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60041
∙ ACT FLUVOXAMINE
∙ fluvoxamine maleate 100 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02255537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74073
∙ RIVA-FLUVOX
∙ fluvoxamine maleate 100 mg;
∙ 2008-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02303361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78869
∙ LUVOX
∙ fluvoxamine maleate 50 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 01919342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11752
∙ APO-FLUVOXAMINE TABLETS
∙ fluvoxamine maleate 50 mg;
∙ 1997-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02231329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50637
∙ FLUVOXAMINE-50
∙ fluvoxamine maleate 50 mg;
∙ 1998-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02236753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60040
∙ ACT FLUVOXAMINE
∙ fluvoxamine maleate 50 mg;
∙ 2004-08-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02255529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74072
∙ RIVA-FLUVOX
∙ fluvoxamine maleate 50 mg;
∙ 2008-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02303345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78867
∙ FOLIC ACID INJECTION USP
∙ folic acid (sodium folate) 5 mg / ml;
∙ 1990-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 88:08.00 – VITAMIN B COMPLEX;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00816086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10312
∙ FOLIC ACID INJECTION, USP
∙ folic acid (sodium folate) 5 mg / ml;
∙ 1996-08-14;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 88:08.00 – VITAMIN B COMPLEX;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02139480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31358
∙ FOLIC ACID
∙ folic acid 5 mg;
∙ 1978-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:08.00 – VITAMIN B COMPLEX;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00426849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3002
∙ SANDOZ FOLIC ACID
∙ folic acid 5 mg;
∙ 2006-11-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:08.00 – VITAMIN B COMPLEX;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02285673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77118
∙ JAMP-FOLIC ACID
∙ folic acid 5 mg;
∙ 2011-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:08.00 – VITAMIN B COMPLEX;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02366061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85094
∙ GONAL-F PEN
∙ follitropin alfa 300 unit / 0.5 ml;
∙ 2005-09-06;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02270404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75578
∙ GONAL-F PEN
∙ follitropin alfa 450 unit / 0.75 ml;
∙ 2005-09-06;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02270390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75577
∙ GONAL-F
∙ follitropin alfa 5.5 mcg / vial;
∙ 2003-12-29;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02248154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72486
∙ GONAL-F PEN
∙ follitropin alfa 900 unit / 1.5 ml;
∙ 2005-09-06;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02270382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75576
∙ PUREGON
∙ follitropin beta 833 unit / ml;
∙ 2001-10-18;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ORGANON CANADA INC.;
∙ DIN: 02243948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67891
∙ REKOVELLE
∙ follitropin delta 12 mcg / 0.36 ml;
∙ 2019-11-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ FERRING INC;
∙ DIN: 02487462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97762
∙ REKOVELLE
∙ follitropin delta 36 mcg / 1.08 ml;
∙ 2019-11-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ FERRING INC;
∙ DIN: 02487470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97763
∙ REKOVELLE
∙ follitropin delta 72 mcg / 2.16 ml;
∙ 2019-11-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ FERRING INC;
∙ DIN: 02487489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97764
∙ ANTIZOL
∙ fomepizole 1 g / ml;
∙ 2001-03-30;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 92:12.00 – ANTIDOTES;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02242980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66820
∙ FOMEPIZOLE FOR INJECTION
∙ fomepizole 1 g / ml;
∙ 2015-09-22;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 92:12.00 – ANTIDOTES;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02435667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92000
∙ ARIXTRA
∙ fondaparinux sodium 2.5 mg / 0.5 ml;
∙ 2002-07-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02245531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69618
∙ FONDAPARINUX SODIUM INJECTION
∙ fondaparinux sodium 2.5 mg / 0.5 ml;
∙ 2014-03-21;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02406853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89154
∙ ARIXTRA
∙ fondaparinux sodium 7.5 mg / 0.6 ml;
∙ 2008-04-17;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02258056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74328
∙ FONDAPARINUX SODIUM INJECTION
∙ fondaparinux sodium 7.5 mg / 0.6 ml;
∙ 2014-03-21;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02406896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89156
∙ FORADIL DRY POWDER CAPSULES FOR INHALATION
∙ formoterol fumarate 12 mcg;
∙ 1997-07-08;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02230898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50160
∙ OXEZE TURBUHALER
∙ formoterol fumarate dihydrate 12 mcg / act;
∙ 1998-03-12;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02237224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60542
∙ OXEZE TURBUHALER
∙ formoterol fumarate dihydrate 6 mcg / act;
∙ 1998-03-12;
∙ Inhalation | Inhalation;
∙ Powder | Poudre;
∙ 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02237225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60543
∙ TELZIR
∙ fosamprenavir (fosamprenavir calcium) 50 mg / ml;
∙ 2005-02-23;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02261553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74693
∙ TELZIR
∙ fosamprenavir (fosamprenavir calcium) 700 mg;
∙ 2004-12-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02261545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74692
∙ EMEND IV
∙ fosaprepitant (fosaprepitant dimeglumine) 150 mg / vial;
∙ 2011-04-04;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02363356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84835
∙ VOCARVI
∙ foscarnet sodium 24 mg / ml;
∙ 2021-03-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.92 – MISCELLANEOUS ANTIVIRALS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02505924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99528
∙ IVOZFO
∙ fosfomycin (fosfomycin sodium) 4 g / vial;
∙ 2020-02-12;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:36.00 – URINARY ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ VERITY PHARMACEUTICALS INC.;
∙ DIN: 02488086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97819
∙ MONUROL
∙ fosfomycin (fosfomycin tromethamine) 3 g / sachet;
∙ 1999-09-15;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:36.00 – URINARY ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02240335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63874
∙ JAMP-FOSFOMYCIN
∙ fosfomycin (fosfomycin tromethamine) 3 g / sachet;
∙ 2018-08-02;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:36.00 – URINARY ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02473801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96331
∙ TEVA-FOSINOPRIL
∙ fosinopril sodium 10 mg;
∙ 2003-12-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02247802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72096
∙ APO-FOSINOPRIL
∙ fosinopril sodium 10 mg;
∙ 2005-04-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02266008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75144
∙ FOSINOPRIL
∙ fosinopril sodium 10 mg;
∙ 2017-04-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02459388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94662
∙ TEVA-FOSINOPRIL
∙ fosinopril sodium 20 mg;
∙ 2003-12-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02247803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72097
∙ APO-FOSINOPRIL
∙ fosinopril sodium 20 mg;
∙ 2005-04-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02266016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75145
∙ FOSINOPRIL
∙ fosinopril sodium 20 mg;
∙ 2017-04-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02459396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94663
∙ CEREBYX
∙ fosphenytoin sodium 75 mg / ml;
∙ 2000-03-01;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 28:12.12 – HYDANTOINS;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 02230988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50269
∙ TAVALISSE
∙ fostamatinib (fostamatinib disodium) 100 mg;
∙ 2020-12-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:28.16 – HEMOSTATICS;
∙ Prescription | Prescription;
∙ MEDISON PHARMA CANADA INC.;
∙ DIN: 02508052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99741
∙ TAVALISSE
∙ fostamatinib (fostamatinib disodium) 150 mg;
∙ 2020-12-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:28.16 – HEMOSTATICS;
∙ Prescription | Prescription;
∙ MEDISON PHARMA CANADA INC.;
∙ DIN: 02508060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99742
∙ AJOVY
∙ fremanezumab 225 mg / 1.5 ml;
∙ 2020-08-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ TEVA CANADA LIMITED;
∙ DIN: 02497859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98765
∙ AJOVY
∙ fremanezumab 225 mg / 1.5 ml;
∙ 2021-04-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ TEVA CANADA LIMITED;
∙ DIN: 02509474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99876
∙ APO-FROVATRIPTAN
∙ frovatriptan (frovatriptan succinate monohydrate) 2.5 mg;
∙ 2014-08-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02426471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91106
∙ JAMP FROVATRIPTAN
∙ frovatriptan (frovatriptan succinate monohydrate) 2.5 mg;
∙ 2021-01-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02497131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98700
∙ FROVA
∙ frovatriptan (frovatriptan succinate) 2.5 mg;
∙ 2008-01-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ ENDO PHARMACEUTICALS INC.;
∙ DIN: 02257084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74230
∙ TEVA-FROVATRIPTAN
∙ frovatriptan (frovatriptan succinate) 2.5 mg;
∙ 2015-01-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ ENDO PHARMACEUTICALS INC.;
∙ DIN: 02415844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90043
∙ FASLODEX
∙ fulvestrant 50 mg / ml;
∙ 2004-06-14;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02248624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72981
∙ TEVA-FULVESTRANT INJECTION
∙ fulvestrant 50 mg / ml;
∙ 2019-01-15;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02460130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94743
∙ FULVESTRANT INJECTION
∙ fulvestrant 50 mg / ml;
∙ 2020-04-27;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02468549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95697
∙ FULVESTRANT INJECTION
∙ fulvestrant 50 mg / ml;
∙ 2019-02-01;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02483610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97398
∙ FUROSEMIDE INJ USP
∙ furosemide 10 mg / ml;
∙ 1981-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00527033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4431
∙ LASIX ORAL SOLUTION 10MG/ML
∙ furosemide 10 mg / ml;
∙ 1996-12-04;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02224720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37372
∙ FUROSEMIDE INJECTION SDZ
∙ furosemide 10 mg / ml;
∙ 2012-07-26;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02382539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86837
∙ FUROSEMIDE INJECTION USP
∙ furosemide 10 mg / ml;
∙ 2017-07-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02461404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94899
∙ FUROSEMIDE INJECTION USP
∙ furosemide 10 mg / ml;
∙ 2021-05-10;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02480530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97109
∙ TEVA-FUROSEMIDE
∙ furosemide 20 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00337730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2333
∙ APO FUROSEMIDE TAB 20MG
∙ furosemide 20 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00396788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2798
∙ FUROSEMIDE 20 TAB
∙ furosemide 20 mg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00496723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3809
∙ FUROSEMIDE
∙ furosemide 20 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83669
∙ MINT-FUROSEMIDE
∙ furosemide 20 mg;
∙ 2018-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02466759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95511
∙ FUROSEMIDE INJECTION USP
∙ furosemide 20 mg / 2 ml;
∙ 2013-08-22;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ TELIGENT OU;
∙ DIN: 02384094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86984
∙ FUROSEMIDE SPECIAL
∙ furosemide 250 mg / 25 ml;
∙ 1991-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00401633
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12218
∙ TEVA-FUROSEMIDE
∙ furosemide 40 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00337749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2447
∙ APO FUROSEMIDE TAB 40MG
∙ furosemide 40 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00362166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2472
∙ FUROSEMIDE 40MG
∙ furosemide 40 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00397792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2851
∙ FUROSEMIDE
∙ furosemide 40 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83670
∙ MINT-FUROSEMIDE
∙ furosemide 40 mg;
∙ 2018-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02466767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95512
∙ LASIX SPECIAL
∙ furosemide 500 mg;
∙ 1997-08-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02224755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37375
∙ APO FUROSEMIDE TAB 80MG
∙ furosemide 80 mg;
∙ 1986-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00707570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6827
∙ TEVA-FUROSEMIDE
∙ furosemide 80 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00765953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9240
∙ FUROSEMIDE-80 TAB 80MG
∙ furosemide 80 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00667080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19189
∙ FUROSEMIDE
∙ furosemide 80 mg;
∙ 2010-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02351447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83671
∙ MINT-FUROSEMIDE
∙ furosemide 80 mg;
∙ 2018-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02466775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95513
∙ FUCIDIN OINTMENT 2%
∙ fusidate sodium 2 %;
∙ 1984-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 00586676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5638
∙ FUCITHALMIC
∙ fusidic acid 1 % / w/w;
∙ 2001-08-29;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ AMDIPHARM LIMITED;
∙ DIN: 02243862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67803
∙ FUCIDIN CREAM 2%
∙ fusidic acid 2 %;
∙ 1984-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 00586668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5637
∙ NEURONTIN
∙ gabapentin 100 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02084260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15944
∙ PMS-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2001-02-23;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02243446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67356
∙ APO-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2001-08-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02244304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68271
∙ TEVA-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2002-06-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02244513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68490
∙ GABAPENTIN
∙ gabapentin 100 mg;
∙ 2003-01-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02246314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70477
∙ RIVA-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2004-03-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02251167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73612
∙ PRO-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79608
∙ AURO-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2011-06-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02321203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80660
∙ GABAPENTIN
∙ gabapentin 100 mg;
∙ 2010-07-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83846
∙ JAMP-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2011-09-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02361469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84654
∙ MAR-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2014-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02391473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87682
∙ GABAPENTIN CAPSULES USP
∙ gabapentin 100 mg;
∙ 2014-06-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02416840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90145
∙ PRIVA-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2017-06-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02450097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93612
∙ AG-GABAPENTIN
∙ gabapentin 100 mg;
∙ 2018-09-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96813
∙ NEURONTIN
∙ gabapentin 300 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02084279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15945
∙ PMS-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2001-02-23;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02243447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67357
∙ APO-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2001-08-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02244305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68273
∙ TEVA-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2002-06-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02244514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68491
∙ GABAPENTIN
∙ gabapentin 300 mg;
∙ 2003-01-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02246315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70478
∙ RIVA-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2004-03-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02251175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73613
∙ PRO-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79609
∙ RAN-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2009-01-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02319063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80455
∙ AURO-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2011-06-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02321211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80661
∙ GABAPENTIN
∙ gabapentin 300 mg;
∙ 2010-07-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83847
∙ JAMP-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2011-09-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02361485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84656
∙ MAR-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2014-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02391481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87683
∙ GABAPENTIN CAPSULES USP
∙ gabapentin 300 mg;
∙ 2014-06-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02416859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90146
∙ PRIVA-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2017-06-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02450100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93613
∙ AG-GABAPENTIN
∙ gabapentin 300 mg;
∙ 2018-09-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96814
∙ NEURONTIN
∙ gabapentin 400 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02084287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16210
∙ PMS-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2001-02-23;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02243448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67358
∙ APO-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2001-08-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02244306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68274
∙ TEVA-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2002-06-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02244515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68492
∙ GABAPENTIN
∙ gabapentin 400 mg;
∙ 2003-01-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02246316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70479
∙ RIVA-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2004-03-25;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02251183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73614
∙ PRO-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79610
∙ AURO-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2011-06-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02321238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80662
∙ GABAPENTIN
∙ gabapentin 400 mg;
∙ 2010-07-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83848
∙ JAMP-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2011-09-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02361493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84657
∙ MAR-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2014-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02391503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87684
∙ GABAPENTIN CAPSULES USP
∙ gabapentin 400 mg;
∙ 2014-06-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02416867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90147
∙ PRIVA-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2017-06-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02450119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93614
∙ AG-GABAPENTIN
∙ gabapentin 400 mg;
∙ 2018-09-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96815
∙ NEURONTIN
∙ gabapentin 600 mg;
∙ 2000-05-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02239717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63199
∙ TEVA-GABAPENTIN
∙ gabapentin 600 mg;
∙ 2003-11-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02248457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72809
∙ APO-GABAPENTIN
∙ gabapentin 600 mg;
∙ 2008-06-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02293358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77872
∙ PRO-GABAPENTIN
∙ gabapentin 600 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79611
∙ GABAPENTIN
∙ gabapentin 600 mg;
∙ 2012-06-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87375
∙ GABAPENTIN TABLETS USP
∙ gabapentin 600 mg;
∙ 2012-10-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02392526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87778
∙ JAMP-GABAPENTIN TABLETS
∙ gabapentin 600 mg;
∙ 2013-05-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02402289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88713
∙ GLN-GABAPENTIN
∙ gabapentin 600 mg;
∙ 2016-04-04;
∙ Oral | Orale;
∙ Tablet (Immediate Release) | Comprimé (À Libération Immédiate);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02410990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89563
∙ AURO-GABAPENTIN TABLETS
∙ gabapentin 600 mg;
∙ 2019-01-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02428334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91281
∙ GABAPENTIN
∙ gabapentin 600 mg;
∙ 2014-09-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02431289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91570
∙ BIO-GABAPENTIN
∙ gabapentin 600 mg;
∙ 2017-06-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02450186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93620
∙ NEURONTIN
∙ gabapentin 800 mg;
∙ 2000-05-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02239718
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63200
∙ TEVA-GABAPENTIN
∙ gabapentin 800 mg;
∙ 2003-06-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02247346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71589
∙ APO-GABAPENTIN
∙ gabapentin 800 mg;
∙ 2008-06-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02293366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77873
∙ PRO-GABAPENTIN
∙ gabapentin 800 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79612
∙ GABAPENTIN
∙ gabapentin 800 mg;
∙ 2012-06-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87376
∙ GABAPENTIN TABLETS USP
∙ gabapentin 800 mg;
∙ 2012-10-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02392534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87779
∙ JAMP-GABAPENTIN TABLETS
∙ gabapentin 800 mg;
∙ 2013-05-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02402297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88714
∙ GLN-GABAPENTIN
∙ gabapentin 800 mg;
∙ 2016-04-04;
∙ Oral | Orale;
∙ Tablet (Immediate Release) | Comprimé (À Libération Immédiate);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02411008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89564
∙ AURO-GABAPENTIN TABLETS
∙ gabapentin 800 mg;
∙ 2019-01-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02428342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91282
∙ GABAPENTIN
∙ gabapentin 800 mg;
∙ 2014-09-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02431297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91571
∙ BIO-GABAPENTIN
∙ gabapentin 800 mg;
∙ 2019-07-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02450194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93621
∙ MULTIHANCE
∙ gadobenate dimeglumine 529 mg / ml;
∙ 2004-10-28;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BRACCO IMAGING CANADA;
∙ DIN: 02248302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72643
∙ GADOVIST 1.0
∙ gadobutrol 604.72 mg / ml;
∙ 2004-01-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAYER INC;
∙ DIN: 02241089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64684
∙ OMNISCAN
∙ gadodiamide 287 mg / ml;
∙ 1997-03-25;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ GE HEALTHCARE CANADA INC;
∙ DIN: 02172771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44188
∙ MAGNEVIST
∙ gadopentetate dimeglumine 469 mg / ml;
∙ 1992-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAYER INC;
∙ DIN: 01989987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13384
∙ DOTAREM
∙ gadoterate meglumine 376.9 mg / ml;
∙ 2017-09-22;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ GUERBET;
∙ DIN: 02459329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94652
∙ PROHANCE – LIQ IV 279.3MG/ML
∙ gadoteridol 279.3 mg / ml;
∙ 1998-09-08;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BRACCO IMAGING CANADA;
∙ DIN: 02229056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43507
∙ PRIMOVIST
∙ gadoxetate disodium 181.43 mg / ml;
∙ 2010-02-04;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 36:89.00* – OTHER DIAGNOSTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAYER INC;
∙ DIN: 02340666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82625
∙ PAT-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 16 mg;
∙ 2011-01-05;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02316951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80245
∙ MYLAN-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 16 mg;
∙ 2010-11-12;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02339447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82506
∙ PMS-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 16 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02398389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88333
∙ AURO-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 16 mg;
∙ 2014-06-12;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02425165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90982
∙ GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 16 mg;
∙ 2016-01-11;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02443023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92758
∙ PAT-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 24 mg;
∙ 2011-01-05;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02316978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80246
∙ MYLAN-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 24 mg;
∙ 2010-11-12;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02339455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82507
∙ PMS-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 24 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02398397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88334
∙ AURO-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 24 mg;
∙ 2014-06-12;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02425173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90983
∙ GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 24 mg;
∙ 2016-01-11;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02443031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92759
∙ PAT-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 8 mg;
∙ 2011-01-05;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02316943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80244
∙ MYLAN-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 8 mg;
∙ 2010-11-12;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02339439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82505
∙ PMS-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 8 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02398370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88332
∙ AURO-GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 8 mg;
∙ 2014-06-12;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02425157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90981
∙ GALANTAMINE ER
∙ galantamine (galantamine hydrobromide) 8 mg;
∙ 2016-01-11;
∙ Oral | Orale;
∙ Capsule (Extended Release) | Capsule (À Libération Prolongée);
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02443015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92757
∙ EMGALITY
∙ galcanezumab 100 mg / ml;
∙ 2021-01-11;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02505134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99448
∙ EMGALITY
∙ galcanezumab 120 mg / ml;
∙ 2019-10-07;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02491060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98107
∙ EMGALITY
∙ galcanezumab 120 mg / ml;
∙ 2019-10-02;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02491087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98110
∙ NAGLAZYME
∙ galsulfase 1 mg / ml;
∙ 2014-01-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Schedule D | Annexe D;
∙ BIOMARIN PHARMACEUTICAL INC.;
∙ DIN: 02412683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89735
∙ CYTOVENE
∙ ganciclovir (ganciclovir sodium) 500 mg / vial;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02162695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19553
∙ GANCICLOVIR FOR INJECTION
∙ ganciclovir (ganciclovir sodium) 500 mg / vial;
∙ 2014-04-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02404761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88956
∙ GANCICLOVIR FOR INJECTION USP
∙ ganciclovir (ganciclovir sodium) 500 mg / vial;
∙ 2021-07-19;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02475391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96577
∙ ORGALUTRAN
∙ ganirelix (ganirelix acetate) 250 mcg / 0.5 ml;
∙ 2002-08-23;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02245641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69741
∙ APO-GATIFLOXACIN
∙ gatifloxacin (gatifloxacin hemihydrate) 0.3 %;
∙ 2019-11-15;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02327260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81256
∙ ZYMAR
∙ gatifloxacin 0.3 %;
∙ 2004-09-27;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02257270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74247
∙ IRESSA
∙ gefitinib 250 mg;
∙ 2003-12-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02248676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73040
∙ APO-GEFITINIB
∙ gefitinib 250 mg;
∙ 2017-10-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02468050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95642
∙ SANDOZ GEFITINIB
∙ gefitinib 250 mg;
∙ 2019-06-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02487748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97788
∙ NAT-GEFITINIB
∙ gefitinib 250 mg;
∙ 2019-11-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02491796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98180
∙ JAMP GEFITINIB
∙ gefitinib 250 mg;
∙ 2020-12-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02500663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99033
∙ GEMCITABINE FOR INJECTION
∙ gemcitabine (gemcitabine hydrochloride) 1 g / vial;
∙ 2009-07-16;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02324210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80969
∙ GEMCITABINE FOR INJECTION
∙ gemcitabine (gemcitabine hydrochloride) 2 g / vial;
∙ 2011-08-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02370034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85506
∙ GEMCITABINE INJECTION
∙ gemcitabine (gemcitabine hydrochloride) 38 mg / ml;
∙ 2013-03-20;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02402831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88767
∙ GEMCITABINE INJECTION
∙ gemcitabine (gemcitabine hydrochloride) 40 mg / ml;
∙ 2013-09-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02412292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89685
∙ TEVA-GEMFIBROZIL
∙ gemfibrozil 300 mg;
∙ 2000-02-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02241704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65364
∙ TEVA-GEMFIBROZIL
∙ gemfibrozil 600 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02142074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17230
∙ MYLOTARG
∙ gemtuzumab ozogamicin 4.5 mg / vial;
∙ 2020-03-11;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02494388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98440
∙ GENTAMICIN(E)
∙ gentamicin (gentamicin sulfate) 1 mg / ml;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02082136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18242
∙ GENTAMICIN(E)
∙ gentamicin (gentamicin sulfate) 1.6 mg / ml;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02082152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18243
∙ GENTAMICIN INJECTION USP
∙ gentamicin (gentamicin sulfate) 10 mg / ml;
∙ 2005-08-29;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02268531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75394
∙ GENTAMICIN INJECTION USP
∙ gentamicin (gentamicin sulfate) 10 mg / ml;
∙ 2019-05-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ TELIGENT OU;
∙ DIN: 02470462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95943
∙ GENTAMICIN INJECTION USP
∙ gentamicin (gentamicin sulfate) 40 mg / ml;
∙ 2000-12-20;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02242652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66434
∙ GENTAMICIN INJECTION USP
∙ gentamicin (gentamicin sulfate) 40 mg / ml;
∙ 2017-01-05;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ TELIGENT OU;
∙ DIN: 02457008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94412
∙ XOSPATA
∙ gilteritinib (gilteritinib fumarate) 40 mg;
∙ 2020-02-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTELLAS PHARMA CANADA INC;
∙ DIN: 02495058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98500
∙ GIVLAARI
∙ givosiran (givosiran sodium) 189 mg / ml;
∙ 2020-12-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ ALNYLAM NETHERLANDS B.V.;
∙ DIN: 02506343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99566
∙ DAURISMO
∙ glasdegib (glasdegib maleate) 100 mg;
∙ 2020-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02498480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98825
∙ DAURISMO
∙ glasdegib (glasdegib maleate) 25 mg;
∙ 2020-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02498472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98824
∙ COPAXONE
∙ glatiramer acetate 20 mg / ml;
∙ 2002-05-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02245619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69719
∙ GLATECT
∙ glatiramer acetate 20 mg / ml;
∙ 2017-08-21;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02460661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94809
∙ COPAXONE
∙ glatiramer acetate 40 mg / ml;
∙ 2016-08-26;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:20.00 – Immunomodulatory Agents;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02456915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94398
∙ DIAMICRON MR
∙ gliclazide 30 mg;
∙ 2001-04-04;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02242987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66827
∙ APO-GLICLAZIDE MR
∙ gliclazide 30 mg;
∙ 2008-06-04;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02297795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78313
∙ MINT-GLICLAZIDE MR
∙ gliclazide 30 mg;
∙ 2014-06-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02423286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90799
∙ MYLAN-GLICLAZIDE MR
∙ gliclazide 30 mg;
∙ 2015-08-07;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02438658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92302
∙ SANDOZ GLICLAZIDE MR
∙ gliclazide 30 mg;
∙ 2017-06-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02461323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94883
∙ TARO-GLICLAZIDE MR
∙ gliclazide 30 mg;
∙ 2018-04-03;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02463571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95168
∙ DIAMICRON MR
∙ gliclazide 60 mg;
∙ 2010-12-09;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 02356422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84157
∙ APO-GLICLAZIDE MR
∙ gliclazide 60 mg;
∙ 2015-04-14;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02407124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89182
∙ TARO-GLICLAZIDE MR
∙ gliclazide 60 mg;
∙ 2016-06-01;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02439328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92369
∙ SANDOZ GLICLAZIDE MR
∙ gliclazide 60 mg;
∙ 2017-06-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02461331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94884
∙ DIAMICRON
∙ gliclazide 80 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SERVIER CANADA INC;
∙ DIN: 00765996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10918
∙ TEVA-GLICLAZIDE
∙ gliclazide 80 mg;
∙ 1998-06-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02238103
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61497
∙ APO-GLICLAZIDE
∙ gliclazide 80 mg;
∙ 2002-07-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02245247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69269
∙ GLICLAZIDE
∙ gliclazide 80 mg;
∙ 2010-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02287072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77250
∙ SANDOZ GLIMEPIRIDE
∙ glimepiride 1 mg;
∙ 2005-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02269589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75494
∙ SANDOZ GLIMEPIRIDE
∙ glimepiride 2 mg;
∙ 2005-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02269597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75495
∙ SANDOZ GLIMEPIRIDE
∙ glimepiride 4 mg;
∙ 2005-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02269619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75497
∙ GLUCAGEN
∙ glucagon (recombinant dna origin) (glucagon hydrochloride) 1 mg / vial;
∙ 2010-01-04;
∙ Intramuscular | Intramusculaire;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 68:22.12 – GLYCOGENOLYTIC AGENTS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02333619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81923
∙ GLUCAGEN HYPOKIT
∙ glucagon (recombinant dna origin) (glucagon hydrochloride) 1 mg / vial;
∙ 2009-12-23;
∙ Intramuscular | Intramusculaire;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 68:22.12 – GLYCOGENOLYTIC AGENTS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02333627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81924
∙ GLUCAGON
∙ glucagon (recombinant dna origin) 1 mg / vial;
∙ 2002-05-27;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 68:22.12 – GLYCOGENOLYTIC AGENTS;
∙ Schedule D | Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02243297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67195
∙ BAQSIMI
∙ glucagon 3 mg / container;
∙ 2019-11-20;
∙ Nasal | Nasale;
∙ Powder | Poudre;
∙ 68:22.12 – GLYCOGENOLYTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ ELI LILLY CANADA INC;
∙ DIN: 02492415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98243
∙ APO GLYBURIDE TAB 2.5MG
∙ glyburide 2.5 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 01913654
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11728
∙ TEVA-GLYBURIDE
∙ glyburide 2.5 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01913670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11780
∙ GLYBURIDE
∙ glyburide 2.5 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 01959352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12865
∙ GLYBURIDE
∙ glyburide 2.5 mg;
∙ 2010-05-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02350459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83566
∙ APO GLYBURIDE TAB 5MG
∙ glyburide 5 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 01913662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11727
∙ TEVA-GLYBURIDE
∙ glyburide 5 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01913689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11781
∙ GLYBURIDE
∙ glyburide 5 mg;
∙ 2010-05-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02350467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83567
∙ GLYBURIDE
∙ glyburide 5 mg;
∙ 2019-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.20 – SULFONYLUREAS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02485664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97589
∙ RAVICTI
∙ glycerol phenylbutyrate 1.1 g / ml;
∙ 2016-11-03;
∙ Oral | Orale;
∙ Liquid | Liquide;
∙ -;
∙ Prescription | Prescription;
∙ HORIZON THERAPEUTICS IRELAND DAC;
∙ DIN: 02453304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93983
∙ GLYCINE 1.5% IRRIGATION USP SOL
∙ glycine 1.5 g / 100 ml;
∙ 1989-12-31;
∙ Irrigation | Irrigation;
∙ Liquid | Liquide;
∙ 40:36.00 – IRRIGATING SOLUTIONS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00799955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9828
∙ GLYCINE IRRIGATION USP
∙ glycine 15 mg / ml;
∙ 1980-12-31;
∙ Irrigation | Irrigation;
∙ Solution | Solution;
∙ 40:36.00 – IRRIGATING SOLUTIONS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00498793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3865
∙ GLYCOPYRROLATE INJECTION USP
∙ glycopyrrolate 0.2 mg / ml;
∙ 1993-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02039508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14577
∙ GLYCOPYRROLATE INJECTION MULTIDOSE
∙ glycopyrrolate 0.2 mg / ml;
∙ 2012-07-13;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02382849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86865
∙ GLYCOPYRROLATE INJECTION
∙ glycopyrrolate 0.2 mg / ml;
∙ 2012-06-29;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02382857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86866
∙ GLYCOPYRROLATE INJECTION USP
∙ glycopyrrolate 0.2 mg / 1 ml;
∙ 2021-05-26;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02473879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96360
∙ GLYCOPYRROLATE INJECTION USP
∙ glycopyrrolate 0.4 mg / 2 ml;
∙ 2021-05-26;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02473895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96361
∙ CUVPOSA
∙ glycopyrrolate 1 mg / 5 ml;
∙ 2018-04-03;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ MEDEXUS PHARMACEUTICALS INC;
∙ DIN: 02469332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95811
∙ GLYCOPYRROLATE INJECTION USP
∙ glycopyrrolate 4 mg / 20 ml;
∙ 2021-05-26;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02473887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96362
∙ SEEBRI BREEZHALER
∙ glycopyrronium (glycopyrronium bromide) 50 mcg;
∙ 2013-01-14;
∙ Inhalation | Inhalation;
∙ Capsule | Capsule;
∙ 48:12.08 – ANTICHOLINERGIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02394936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88007
∙ SIMPONI
∙ golimumab 100 mg / 1.0 ml;
∙ 2013-10-03;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02413175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89785
∙ SIMPONI
∙ golimumab 100 mg / 1.0 ml;
∙ 2013-10-03;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02413183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89786
∙ SIMPONI
∙ golimumab 50 mg / 0.5 ml;
∙ 2009-06-22;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02324776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81020
∙ SIMPONI
∙ golimumab 50 mg / 0.5 ml;
∙ 2009-06-22;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02324784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81021
∙ SIMPONI I.V.
∙ golimumab 50 mg / 4.0 ml;
∙ 2013-12-12;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02417472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90217
∙ LUTREPULSE PWS 0.8MG/VIAL
∙ gonadorelin acetate 0.8 mg / vial;
∙ 1994-12-31;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02046210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16274
∙ ZOLADEX LA
∙ goserelin (goserelin acetate) 10.8 mg;
∙ 1996-08-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Implant | Implant;
∙ 92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ TERSERA THERAPEUTICS LLC;
∙ DIN: 02225905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43433
∙ ZOLADEX
∙ goserelin (goserelin acetate) 3.6 mg;
∙ 1994-12-31;
∙ Subcutaneous | Sous-Cutanée;
∙ Implant | Implant;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription | Prescription;
∙ TERSERA THERAPEUTICS LLC;
∙ DIN: 02049325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16216
∙ APO-GRANISETRON
∙ granisetron (granisetron hydrochloride) 1 mg;
∙ 2009-02-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02308894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79450
∙ NAT-GRANISETRON
∙ granisetron (granisetron hydrochloride) 1 mg;
∙ 2016-03-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02452359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93873
∙ JAMP GRANISETRON
∙ granisetron (granisetron hydrochloride) 1 mg;
∙ 2020-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02472686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96198
∙ GRANISETRON HYDROCHLORIDE INJECTION
∙ granisetron (granisetron hydrochloride) 1 mg / ml;
∙ 2009-05-14;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02322765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80824
∙ ORALAIR
∙ grass pollen allergen extract 100 unit;
∙ 2012-07-26;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ STALLERGENES CANADA INC;
∙ DIN: 02381885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86772
∙ ORALAIR
∙ grass pollen allergen extract 300 unit;
∙ 2012-07-26;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ STALLERGENES CANADA INC;
∙ DIN: 02381893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86773
∙ ROBITUSSIN MUCUS & PHLEGM
∙ guaifenesin 100 mg / 5 ml;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 01931032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11918
∙ BRONCHOPHAN EXPECTORANT (SANS SUCROSE)
∙ guaifenesin 100 mg / 5 ml;
∙ 1999-03-10;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 02121999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=30557
∙ BALMINIL EXPECTORANT (SUCROSE FREE)
∙ guaifenesin 100 mg / 5 ml;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00609951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41989
∙ ROBITUSSIN EXTRA STRENGTH MUCUS AND PHLEGM
∙ guaifenesin 200 mg / 5 ml;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02142783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19044
∙ MUCUS & PHLEGM RELIEF EXTRA STRENGTH
∙ guaifenesin 200 mg / 5 ml;
∙ 2013-08-29;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ TRILLIUM HEALTH CARE PRODUCTS INC;
∙ DIN: 02405865
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89063
∙ MUCINEX CHEST CONGESTION
∙ guaifenesin 600 mg;
∙ 2016-08-05;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 48:16.00 – EXPECTORANTS;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 02434725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91903
∙ INTUNIV XR
∙ guanfacine (guanfacine hydrochloride) 1 mg;
∙ 2013-08-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02409100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89383
∙ INTUNIV XR
∙ guanfacine (guanfacine hydrochloride) 2 mg;
∙ 2013-08-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02409119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89384
∙ INTUNIV XR
∙ guanfacine (guanfacine hydrochloride) 3 mg;
∙ 2013-08-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02409127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89385
∙ INTUNIV XR
∙ guanfacine (guanfacine hydrochloride) 4 mg;
∙ 2013-08-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02409135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89386
∙ TREMFYA
∙ guselkumab 100 mg / 1 ml;
∙ 2017-11-27;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02469758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95860
∙ TREMFYA ONE-PRESS
∙ guselkumab 100 mg / 1 ml;
∙ 2019-05-20;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ JANSSEN INC;
∙ DIN: 02487314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97748

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut